Women's Headache Treatment California

Women's Headache Treatment California

Cluster Headache Treatment

The flexibility of telemedicine appointments allowed him to seek treatment without disrupting his day. First off, let's talk about your diet. Learn more about Women's Headache Treatment California here They consider everything from medication and diet to stress management techniques and physical therapy options. Regular physical activity can reduce the frequency and intensity of migraines for many. Learn more about Haven Headache & Migraine Center here. By understanding the genetic, environmental, and lifestyle factors that trigger your migraines, we're working towards preventative approaches that minimize your migraine episodes and their severity.
Headaches are pain in any region of the head, often described as ranging from mild to severe. Discussing your symptoms and concerns through a screen can sometimes feel less intimidating, making it easier to communicate openly with your healthcare provider. At Haven Headache & Migraine Center, the focus is on understanding the nuances of your condition through comprehensive online consultations. To get started, simply visit the Haven Headache & Migraine Center's website or give them a call. Headache Management Program
Turning to telehealth, she found a specialist who tailored a treatment plan that drastically reduced her migraine frequency and severity. It's straightforward and ensures your appointment addresses your specific needs right from the start. This shift towards online medical services isn't just a trend but a substantial step forward in making healthcare more accessible and tailored to your needs. So, they're not just treating your migraines; they're looking after you, ensuring the treatment plan fits your lifestyle and preferences.
During this session, you can discuss your symptoms, medical history, and any concerns you have just as you'd during an in-person visit. The specialist will assess your situation, offer recommendations, and can even prescribe medication if necessary. You'll also have the opportunity to ask questions and clarify any concerns. Another success story comes from Mike, a busy professional whose chronic headaches made it difficult to maintain his work schedule.

In essence, Haven Headache & Migraine Center offers a comprehensive, ongoing support system designed to empower you in managing your migraines effectively, ensuring you always feel supported and never alone on your path to relief.

Women's Headache Treatment California - Headache Management Program

  1. Cluster Headache Treatment
  2. Headache Disorder Specialists
  3. Headache Management Program
  4. Migraine Pain Management
  5. Neurology Clinic
  6. Neurologists Near Me
  7. Tension Headache Therapy
  8. Pain Management
  9. Migraine Treatment Protocol
  10. Migraine Diagnosis
  11. Headache Specialist
  12. Headache Disorder Specialists
  13. Headache Management Program
  14. Migraine Pain Management
  15. Neurology Clinic
  16. Neurologists Near Me
  17. Tension Headache Therapy
  18. Pain Management
  19. Migraine Treatment Protocol
Imagine waking up each day not knowing if a headache will dictate your schedule. Within weeks of her first virtual consultation, Sarah started experiencing fewer headaches. Migraine Research Instead, you can receive consistent, tailored care from the comfort of your home. Moreover, Haven's commitment to accessibility extends to their scheduling system.

At your appointment time, you'll meet with a specialist who's equipped to diagnose, treat, and manage your headache or migraine through this virtual interface. The specialist will ask detailed questions to understand your condition better and might conduct a virtual examination. Instead, you can receive the same level of care from the comfort of your home. Beyond securing your data, Haven Headache & Migraine Center leverages advanced technology to enhance your telehealth experience.

They're not just treating symptoms; they're addressing the root causes and how migraines impact your life. Building on the foundation laid by our expert team, let's explore how real patients have achieved remarkable relief from their migraines at Haven Headache & Migraine Center. These stories aren't just testimonials; they're beacons of hope. From prescription medications to specialized supplements, you'll receive a comprehensive care package. Neurologists Near Me

Welcome to a community where your well-being is our top priority. The team is led by renowned neurologists who've dedicated their careers to understanding the complexities of migraines and headaches. If you've ever felt alone in your migraine journey, discovering how Haven's holistic and comprehensive approach could change your life might just be the turning point you need. This modern method of care ensures that you're supported every step of the way, with ongoing monitoring and adjustments to your treatment plan as needed.

Migraine And Headache Treatment California

Entity Name Description Source
Headache A pain or discomfort in the head or face area, often caused by various conditions. source
Migraine A neurological condition characterized by intense, debilitating headaches often with nausea. source
Cluster headache Severe headaches occurring in cyclical patterns or clusters, typically around one eye. source
Tension headache A common type of headache caused by muscle tension and stress, resulting in a dull pain. source
Long COVID Prolonged symptoms and health effects following infection with COVID-19. source
Migraine-associated vertigo Vertigo or dizziness occurring in conjunction with migraine headaches. source
Aura (symptom) Sensory disturbances such as visual changes preceding a migraine attack. source
Nausea A sensation of unease and discomfort in the stomach often preceding vomiting. source
Lightheadedness Feeling faint or dizzy, often due to reduced blood flow to the brain. source
Weakness Lack of physical strength or energy in muscles or the body. source
Neck pain Discomfort or pain localized in the neck region, often due to injury or strain. source
Sleep disorder Conditions affecting the quality, timing, and amount of sleep, impacting health. source
Sinusitis Inflammation or infection of the sinus cavities causing pain and congestion. source
Orofacial pain Pain perceived in the face and/or oral cavity, often involving nerves or muscles. source
Trigeminal neuralgia Chronic pain condition affecting the trigeminal nerve in the face, causing severe facial pain. source
Trigeminal nerve The fifth cranial nerve responsible for sensation in the face and motor functions like biting. source
Chronic pain Persistent pain lasting longer than usual recovery time, often beyond 3 months. source
Pain An unpleasant sensory and emotional experience associated with actual or potential tissue damage. source

Pediatric Headache Treatment California

The Greater Los Angeles and San Francisco Bay areas are the nation's second- and fifth-most populous urban regions, with 19 million and 10 million residents respectively. Los Angeles is the state's most populous city and the nation's second-most. California's capital is Sacramento. Part of the Californias region of North America, the state's diverse geography ranges from the Pacific Coast and metropolitan areas in the west to the Sierra Nevada mountains in the east, and from the redwood and Douglas fir forests in the northwest to the Mojave Desert in the southeast. Two-thirds of the nation's earthquake risk lies in California. The Central Valley, a fertile agricultural area, dominates the state's center. The large size of the state results in climates that vary from moist temperate rainforest in the north to arid desert in the interior, as well as snowy alpine in the mountains. Droughts and wildfires are an ongoing issue,[13] while simultaneously, atmospheric rivers are turning increasingly prevalent and leading to intense flooding events—especially in the winter.

Migraine Pain Management California

Nearby Tourist Attractions


Citations and other links

Neurologist Specializing In Headaches Women's Headache Treatment California

Tracking your symptoms, identifying your triggers, and recognizing the early warning signs can help you take control. Neurology Clinic Haven's commitment to ongoing care ensures that you're supported every step of the way towards achieving a better quality of life free from debilitating migraines. You can easily schedule follow-up appointments, monitor your progress, and make adjustments to your treatment plan in real time. Moreover, virtual consultations can be more cost-effective and time-saving. Many services offer consultations during evenings and weekends, ensuring you get the help you need when you need it.

Haven incorporates lifestyle adjustments, dietary recommendations, and stress management techniques into your plan. Changes in weather? You'll discuss your symptoms and concerns in a familiar and secure environment, enhancing the quality of the consultation. Migraine Diagnosis Seeking expert care for headaches and migraines has never been more convenient, thanks to the benefits of online consultations.

If you're a Women's Headache Treatment California resident struggling with the relentless waves of migraine pain, you've likely sought refuge in various treatments with little to no success. Recognizing your unique migraine triggers is a crucial step, but finding the right treatment options at specialized centers like Haven Headache & Migraine Center can significantly improve your quality of life. Building on our commitment to personalized care plans, we also embrace a holistic approach to treating your migraines. This means they not only meet but often exceed, the requirements for privacy and security in healthcare. Pain Management

When your appointment time arrives, you'll log into the platform using your computer or mobile device. Next, you'll schedule a virtual meeting with a Haven migraine specialist. Recognizing early signs of a migraine can help you take action before it fully develops. Here, you'll select an available slot that fits your schedule.

Neurologist Specializing In Headaches Women's Headache Treatment California
Women's Headache Treatment California Neurologist for Headaches and Migraines

Women's Headache Treatment California Neurologist for Headaches and Migraines

Instead, expert advice will be just a video call away, saving you time and hassle.

Women's Headache Treatment California - Pain Management

  • Cluster Headache Treatment
  • Migraine Treatment Options
  • Migraine and Headache Clinic
  • Headache and Migraine Relief
  • Migraine Treatment Protocol
  • Migraine Diagnosis
  • Migraine Support
  • Tension Headache Therapy
  • Headache Specialist
  • Headache Specialist Consultation
  • Headache Relief Center
  • Headache Pain Management
  • Neurology Clinic
  • Headache Relief Techniques
  • Migraine Medication Management
This continuous support and guidance can lead to improved outcomes and a better understanding of how to manage your headaches or migraines effectively. Our goal is to empower you with a comprehensive treatment plan that addresses the root causes of your migraines, not just the symptoms. You can connect with leading headache and migraine experts across Women's Headache Treatment California, ensuring you receive the best possible advice, diagnosis, and treatment plan tailored to your specific needs.

One patient's journey began with weekly, debilitating migraines, rendering her unable to participate in daily activities. Migraines, particularly, can significantly affect your quality of life, leading to missed days of work or school and affecting your ability to participate in daily activities. That's where Haven's telehealth services shine.

Women's Headache Treatment California - Pain Management

  1. Headache Disorder Treatment
  2. Cluster Headache Treatment
  3. Migraine Treatment Options
  4. Migraine and Headache Clinic
  5. Headache and Migraine Relief
  6. Migraine Treatment Protocol
  7. Migraine Diagnosis
  8. Migraine Support
  9. Tension Headache Therapy
  10. Headache Specialist
  11. Headache Specialist Consultation
  12. Headache Relief Center
  13. Headache Pain Management
  14. Neurology Clinic
  15. Headache Relief Techniques
  16. Migraine Medication Management
  17. Migraine Specialist


They've also worked on making their services affordable, accepting a wide range of insurance plans and offering assistance to those who need it. Start by narrowing down specialists who've a strong focus on headache and migraine conditions. Remember, taking the first step towards managing your migraines is a move towards reclaiming your life from chronic pain.

But what sets this service apart in a world where digital health solutions are increasingly common, and how does it integrate into the daily lives of those it aims to help?

Women's Headache Treatment California - Migraine Treatment Protocol

  • Migraine Research
  • Migraine Doctors
  • Migraine Headache Clinic
  • Migraine Headache Relief
  • Neurologists Near Me
  • Pain Relief Specialists
  • Migraine Patient Care
  • Headache Treatment Plan
  • Headache Therapy
  • Neurological Disorders
  • Migraine Headache Diagnosis
  • Migraine Support Groups
  • Migraine Therapy
  • Migraine and Headache Causes
  • Headache Management Program
  • Headache Treatment
  • Recurrent Migraine Treatment
  • Migraine Treatment Clinics
  • Migraine Symptoms
  • Neurological Care
At Haven Headache & Migraine Center, we dive deep into your health history, lifestyle, and the specific characteristics of your migraines.

Women's Headache Treatment California - Cluster Headache Treatment

  • Headache Specialist
  • Neurology Clinic
  • Neurologists Near Me
  • Tension Headache Therapy
  • Pain Management
  • Migraine Treatment Protocol
  • Migraine Diagnosis
  • Headache Specialist
  • Neurology Clinic
  • Neurologists Near Me
  • Tension Headache Therapy
  • Pain Management
  • Migraine Treatment Protocol
  • Migraine Diagnosis
  • Headache Specialist
  • Neurology Clinic
  • Neurologists Near Me
What sets the Haven Approach apart is its emphasis on accessibility and convenience through telehealth services.

Women's Headache Treatment California Pain Relief For Tension Headaches

With personalized care at your fingertips, relief is closer than you think. This collaborative approach fosters a deeper understanding of your condition, paving the way for personalized treatment plans that align with your lifestyle and preferences. Haven's medical professionals are leaders in their field, equipped with the tools to provide top-notch care digitally. Migraine Headache Clinic We'll work with you to identify potential triggers in your diet, daily routine, and environment that may be contributing to your migraines. Moreover, telehealth's rise has empowered you to take control of your health journey.

This means you're not getting a one-size-fits-all approach but rather a strategy that considers your symptoms, triggers, and daily routines. Then there's Emma, who lives in a remote part of Women's Headache Treatment California with limited access to specialized healthcare. You'll find that our center prioritizes lifestyle adjustments, dietary changes, and stress management techniques as key components of your treatment plan. This step ensures your consultation is tailored to your needs right from the start.

She went from chronic daily headaches to enjoying her hobbies again, pain-free. These gatherings are led by experts and cover a wide range of topics, from managing stress and anxiety associated with migraines to exploring new research and treatment options. They'll guide you through lifestyle changes that can significantly impact your migraine experience. It's important to take notes during your consultation or ask for a summary via email so you can refer back to them.

By choosing Haven, you're putting yourself in the hands of specialists who genuinely care and have the skills to make a difference in your life. Plus, Haven's app tracks your progress and symptoms, offering insights that help fine-tune your treatment over time. You can schedule appointments, consult with specialists, and even receive prescriptions online.

Women's Headache Treatment California - Migraine Pain Management

  1. Pain Management
  2. Migraine Treatment Protocol
  3. Migraine Diagnosis
  4. Headache Specialist
  5. Tension Headache Therapy
  6. Pain Management
  7. Migraine Treatment Protocol
  8. Migraine Diagnosis
  9. Headache Specialist
  10. Tension Headache Therapy
  11. Pain Management
  12. Migraine Treatment Protocol
  13. Migraine Diagnosis
  14. Headache Specialist
  15. Tension Headache Therapy
Your journey starts with an in-depth evaluation where you'll share your medical history, symptom patterns, and any previous treatments you've tried.

Women's Headache Treatment California - Migraine Research

  • Headache Specialist
  • Migraine Diagnosis
  • Headache Specialist
  • Migraine Diagnosis
  • Headache Specialist
  • Migraine Diagnosis
  • Headache Specialist
  • Migraine Diagnosis
  • Headache Specialist
  • Migraine Diagnosis
  • Headache Specialist
  • Migraine Diagnosis
  • Headache Specialist
  • Migraine Diagnosis
  • Headache Specialist


Women's Headache Treatment California Pain Relief For Tension Headaches
Advanced Chronic Headache Care Women's Headache Treatment California
Advanced Chronic Headache Care Women's Headache Treatment California

These stories aren't just testimonials; they're proof of the efficacy and convenience of telehealth in treating chronic conditions like migraines. They're also skilled in leveraging telehealth technology, ensuring you have access to their expertise regardless of your location in Women's Headache Treatment California. This isn't a distant dream; it's the near future of migraine management. She's just one of many who've found relief without the stress of commuting to a medical office.
Our goal isn't just to manage your migraines; it's to enhance your overall quality of life.

Women's Headache Treatment California - Neurology Clinic

  • Headache Treatment Plan
  • Headache Therapy
  • Neurological Disorders
  • Migraine Headache Diagnosis
  • Migraine Support Groups
  • Migraine Therapy
  • Migraine and Headache Causes
  • Headache Management Program
  • Headache Treatment
  • Recurrent Migraine Treatment
  • Migraine Treatment Clinics
  • Migraine Symptoms
  • Neurological Care
  • Chronic Migraine Care
  • Chronic Headache Clinic
  • Neurology Consultation
  • Headache Treatment Center
Headache Disorder Specialists Irregular sleep patterns can provoke migraines, so aim for a consistent sleep schedule. When you turn to Haven for your migraine relief, they recognize that a one-size-fits-all approach just doesn't cut it.
Telehealth streamlines chronic care for headache and migraine sufferers by simplifying access to ongoing support and management. This approach not only overcomes traditional barriers but also empowers you to take control of your health journey. They're at the forefront of their fields, continuously updating their knowledge with the latest research and techniques. Headache Specialist Read more about Women's Headache Treatment California here
They understand that managing migraines is about more than just dealing with the pain; it's about enhancing your overall quality of life. This innovative approach not only reflects the rising trend of virtual healthcare but also promises a new level of accessibility and convenience for migraine sufferers. This plan goes beyond medication.

Migraine and Headache Relief Doctors Women's Headache Treatment California

We believe in empowering you with knowledge, so you'll understand not just the 'how' but the 'why' behind your migraines. Tension Headache Therapy To effectively manage migraines, it's crucial to grasp what they are and how they impact your body. When you're seeking care through their telehealth services, you're not just getting convenience; you're also receiving a commitment to your confidentiality. Migraine Doctors You'll receive a clear explanation of how your information is used and safeguarded, giving you control over your medical data.
First, we'll help you understand your insurance policy's specifics. Through telehealth, he got access to a headache specialist who helped him with ergonomic adjustments and prescribed medication that worked wonders. It's breaking down barriers, making it easier for you to manage your health on your terms.
You'll also appreciate the privacy and comfort online consultations offer. It's particularly beneficial for those living in rural or underserved areas, where specialist care is scarce. So, you're not just getting standard care; you're benefiting from the latest in migraine management, all from the comfort of your home.
Living with chronic headaches can significantly disrupt your daily life, making even simple tasks seem insurmountable. Understanding your journey with headaches and migraines, we provide continuous care and unwavering support throughout your treatment. Moreover, Haven's support goes beyond direct medical interventions.

Explore Women's Headache Treatment California here
Migraine and Headache Relief Doctors Women's Headache Treatment California

 

Migraine
Woman during a migraine attack
Specialty Neurology
Symptoms Headaches coupled with sensory disturbances such as nausea, sensitivity to light, sound, and smell
Usual onset Around puberty
Duration Recurrent, long term
Causes Environmental and genetic
Risk factors Family history, female sex
Differential diagnosis Subarachnoid hemorrhage, venous thrombosis, idiopathic intracranial hypertension, brain tumor, tension headache, sinusitis, cluster headache
Prevention Propranolol, amitriptyline, topiramate, calcitonin gene-related peptide receptor antagonists (CGRPs)
Medication Ibuprofen, paracetamol (acetaminophen), triptans, ergotamines
Prevalence ~15%

Migraine ( UK: /ˈmɡrn/,

US: /ˈm-/)[1][2] is a complex neurological disorder characterized by episodes of moderate-to-severe headache, most often unilateral and generally associated with nausea, and light and sound sensitivity.[3][4] Other characterizing symptoms may include vomiting, cognitive dysfunction, allodynia, and dizziness.[3] Exacerbation or worsening of headache symptoms during physical activity is another distinguishing feature.[5]

Up to one-third of people with migraine experience aura, a premonitory period of sensory disturbance widely accepted to be caused by cortical spreading depression at the onset of a migraine attack.[4] Although primarily considered to be a headache disorder, migraine is highly heterogenous in its clinical presentation and is better thought of as a spectrum disease rather than a distinct clinical entity.[6] Disease burden can range from episodic discrete attacks to chronic disease.[6][7]

Migraine is believed to be caused by a mixture of environmental and genetic factors that influence the excitation and inhibition of nerve cells in the brain.[8] The accepted hypothesis suggests that multiple primary neuronal impairments lead to a series of intracranial and extracranial changes, triggering a physiological cascade that leads to migraine symptomatology.[9]

Initial recommended treatment for acute attacks is with over-the-counter analgesics (pain medication) such as ibuprofen and paracetamol (acetaminophen) for headache, antiemetics (anti-nausea medication) for nausea, and the avoidance of migraine triggers.[10] Specific medications such as triptans, ergotamines, or calcitonin gene-related peptide receptor antagonist (CGRP) inhibitors may be used in those experiencing headaches that do not respond to the over-the-counter pain medications.[11] For people who experience four or more attacks per month, or could otherwise benefit from prevention, prophylactic medication is recommended.[12] Commonly prescribed prophylactic medications include beta blockers like propranolol, anticonvulsants like sodium valproate, antidepressants like amitriptyline, and other off-label classes of medications.[13] Preventive medications inhibit migraine pathophysiology through various mechanisms, such as blocking calcium and sodium channels, blocking gap junctions, and inhibiting matrix metalloproteinases, among other mechanisms.[14][15] Non-pharmacological preventive therapies include nutritional supplementation, dietary interventions, sleep improvement, and aerobic exercise.[16] In 2018, the first medication (Erenumab) of a new class of drugs specifically designed for migraine prevention called calcitonin gene-related peptide receptor antagonists (CGRPs) was approved by the FDA.[17] As of July 2023, the FDA has approved eight drugs that act on the CGRP system for use in the treatment of migraine.[18]

Globally, approximately 15% of people are affected by migraine.[19] In the Global Burden of Disease Study, conducted in 2010, migraine ranked as the third-most prevalent disorder in the world.[20] It most often starts at puberty and is worst during middle age.[21] As of 2016, it is one of the most common causes of disability.[22]

Signs and symptoms

[edit]

Migraine typically presents with self-limited, recurrent severe headaches associated with autonomic symptoms.[23][24] About 15–30% of people living with migraine experience episodes with aura,[10][25] and they also frequently experience episodes without aura.[26] The severity of the pain, duration of the headache, and frequency of attacks are variable.[23] A migraine attack lasting longer than 72 hours is termed status migrainosus.[27] There are four possible phases to a migraine attack, although not all the phases are necessarily experienced:[28]

  • The prodrome, which occurs hours or days before the headache
  • The aura, which immediately precedes the headache
  • The pain phase, also known as the headache phase
  • The postdrome, the effects experienced following the end of a migraine attack

Migraine is associated with major depression, bipolar disorder, anxiety disorders, and obsessive–compulsive disorder. These psychiatric disorders are approximately 2–5 times more common in people without aura, and 3–10 times more common in people with aura.[29]

Prodrome phase

[edit]

Prodromal or premonitory symptoms occur in about 60% of those with migraine,[30][31] with an onset that can range from two hours to two days before the start of pain or the aura.[32] These symptoms may include a wide variety of phenomena,[33] including altered mood, irritability, depression or euphoria, fatigue, craving for certain food(s), stiff muscles (especially in the neck), constipation or diarrhea, and sensitivity to smells or noise.[31] This may occur in those with either migraine with aura or migraine without aura.[34] Neuroimaging indicates the limbic system and hypothalamus as the origin of prodromal symptoms in migraine.[35]

Aura phase

[edit]
Enhancements reminiscent of a zigzag fort structure Negative scotoma, loss of awareness of local structures
Positive scotoma, local perception of additional structures Mostly one-sided loss of perception

Aura is a transient focal neurological phenomenon that occurs before or during the headache.[30] Aura appears gradually over a number of minutes (usually occurring over 5–60 minutes) and generally lasts less than 60 minutes.[36][37] Symptoms can be visual, sensory or motoric in nature, and many people experience more than one.[38] Visual effects occur most frequently: they occur in up to 99% of cases, and in more than 50% of cases are not accompanied by sensory or motor effects.[38] If any symptom remains after 60 minutes, the state is known as persistent aura.[39]

Visual disturbances often consist of a scintillating scotoma (an area of partial alteration in the field of vision which flickers and may interfere with a person's ability to read or drive).[30] These typically start near the center of vision and then spread out to the sides with zigzagging lines, which have been described as looking like fortifications or walls of a castle.[38] Usually, the lines are in black and white, but some people also see colored lines.[38] Some people lose part of their field of vision known as hemianopsia while others experience blurring.[38]

Sensory auras are the second most common type; they occur in 30–40% of people with auras.[38] Often, a feeling of pins-and-needles begins on one side in the hand and arm and spreads to the nose–mouth area on the same side.[38] Numbness usually occurs after the tingling has passed with a loss of position sense.[38] Other symptoms of the aura phase can include speech or language disturbances, world spinning, and, less commonly, motor problems.[38] Motor symptoms indicate that this is a hemiplegic migraine, and weakness often lasts longer than one hour unlike other auras.[38] Auditory hallucinations or delusions have also been described.[40]

Pain phase

[edit]

Classically the headache is unilateral, throbbing, and moderate to severe in intensity.[36] It usually comes on gradually[36] and is aggravated by physical activity during a migraine attack.[28] However, the effects of physical activity on migraine are complex, and some researchers have concluded that, while exercise can trigger migraine attacks, regular exercise may have a prophylactic effect and decrease frequency of attacks.[41] The feeling of pulsating pain is not in phase with the pulse.[42] In more than 40% of cases, however, the pain may be bilateral (both sides of the head), and neck pain is commonly associated with it.[43] Bilateral pain is particularly common in those who have migraine without aura.[30] Less commonly pain may occur primarily in the back or top of the head.[30] The pain usually lasts 4 to 72 hours in adults;[36] however, in young children frequently lasts less than 1 hour.[44] The frequency of attacks is variable, from a few in a lifetime to several a week, with the average being about one a month.[45][46]

The pain is frequently accompanied by nausea, vomiting, sensitivity to light, sensitivity to sound, sensitivity to smells, fatigue, and irritability.[30] Many thus seek a dark and quiet room.[47] In a basilar migraine, a migraine with neurological symptoms related to the brain stem or with neurological symptoms on both sides of the body,[48] common effects include a sense of the world spinning, light-headedness, and confusion.[30] Nausea occurs in almost 90% of people, and vomiting occurs in about one-third.[47] Other symptoms may include blurred vision, nasal stuffiness, diarrhea, frequent urination, pallor, or sweating.[49] Swelling or tenderness of the scalp may occur as can neck stiffness.[49] Associated symptoms are less common in the elderly.[50]

Silent migraine

[edit]

Sometimes, aura occurs without a subsequent headache.[38] This is known in modern classification as a typical aura without headache, or acephalgic migraine in previous classification, or commonly as a silent migraine.[51][52] However, silent migraine can still produce debilitating symptoms, with visual disturbance, vision loss in half of both eyes, alterations in color perception, and other sensory problems, like sensitivity to light, sound, and odors.[53] It can last from 15 to 30 minutes, usually no longer than 60 minutes, and it can recur or appear as an isolated event.[54] Many report a sore feeling in the area where the migraine was, and some report impaired thinking for a few days after the headache has passed. The person may feel tired or "hung over" and have head pain, cognitive difficulties, gastrointestinal symptoms, mood changes, and weakness.[55] According to one summary, "Some people feel unusually refreshed or euphoric after an attack, whereas others note depression and malaise."[56][unreliable medical source?]

Cause

[edit]

The underlying cause of migraine is unknown.[57] However, it is believed to be related to a mix of environmental and genetic factors.[8] Migraine runs in families in about two-thirds of cases[23] and rarely occur due to a single gene defect.[58] While migraine attacks were once believed to be more common in those of high intelligence, this does not appear to be true.[45] A number of psychological conditions are associated, including depression, anxiety, and bipolar disorder.[59]

Intracranial cavernous sinus: a potential site where dilation of cerebral vessels can compress multiple cranial nerves.

Success of the surgical migraine treatment by decompression of extracranial sensory nerves adjacent to vessels[60] suggests that people with migraine may have anatomical predisposition for neurovascular compression[61] that may be caused by both intracranial and extracranial vasodilation due to migraine triggers.[62] This, along with the existence of numerous cranial neural interconnections,[63] may explain the multiple cranial nerve involvement and consequent diversity of migraine symptoms.[64]

Genetics

[edit]

Studies of twins indicate a 34–51% genetic influence on the likelihood of developing migraine.[8] This genetic relationship is stronger for migraine with aura than for migraine without aura.[26] It is clear from family and populations studies that migraine is a complex disorder, where numerous genetic risk variants exist, and where each variant increases the risk of migraine marginally.[65][66] It is also known that having several of these risk variants increases the risk by a small to moderate amount.[58]

Single gene disorders that result in migraine are rare.[58] One of these is known as familial hemiplegic migraine, a type of migraine with aura, which is inherited in an autosomal dominant fashion.[67][68] Four genes have been shown to be involved in familial hemiplegic migraine.[69] Three of these genes are involved in ion transport.[69] The fourth is the axonal protein PRRT2, associated with the exocytosis complex.[69] Another genetic disorder associated with migraine is CADASIL syndrome or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.[30] One meta-analysis found a protective effect from angiotensin converting enzyme polymorphisms on migraine.[70] The TRPM8 gene, which codes for a cation channel, has been linked to migraine.[71]

The common forms of migraine are polygenetic, where common variants of numerous genes contribute to the predisposition for migraine. These genes can be placed in three categories, increasing the risk of migraine in general, specifically migraine with aura, or migraine without aura.[72][73] Three of these genes, CALCA, CALCB, and HTR1F are already target for migraine specific treatments. Five genes are specific risk to migraine with aura, PALMD, ABO, LRRK2, CACNA1A and PRRT2, and 13 genes are specific to migraine without aura. Using the accumulated genetic risk of the common variations, into a so-called polygenetic risk, it is possible to assess e.g. the treatment response to triptans.[74][75]

Triggers

[edit]

Migraine may be induced by triggers, with some reporting it as an influence in a minority of cases[23] and others, the majority.[76] Many things, such as fatigue, certain foods, alcohol, and weather, have been labeled as triggers; however, the strength and significance of these relationships are uncertain.[76][77] Most people with migraine report experiencing triggers.[78] Symptoms may start up to 24 hours after a trigger.[23]

Also, evidence shows a strong association between migraine and the quality of sleep, particularly poor subjective quality of sleep. The relationship seems to be bidirectional, as migraine frequency increases with low quality of sleep, yet the underlying mechanism of this correlation remains poorly understood.[79]

Physiological aspects

[edit]

Common triggers quoted are stress, hunger, and fatigue (these equally contribute to tension headaches).[76] Psychological stress has been reported as a factor by 50–80% of people.[80] Migraine has also been associated with post-traumatic stress disorder and abuse.[81] Migraine episodes are more likely to occur around menstruation.[80] Other hormonal influences, such as menarche, oral contraceptive use, pregnancy, perimenopause, and menopause, also play a role.[82] These hormonal influences seem to play a greater role in migraine without aura.[45] Migraine episodes typically do not occur during the second and third trimesters of pregnancy, or following menopause.[30]

Dietary aspects

[edit]

Between 12% and 60% of people report foods as triggers.[83][84]

There are many reports[85][86][87][88][89] that tyramine – which is naturally present in chocolate, alcoholic beverages, most cheeses, processed meats, and other foods – can trigger migraine symptoms in some individuals. Monosodium glutamate (MSG) has been reported as a trigger for migraine,[90] but a systematic review concluded that "a causal relationship between MSG and headache has not been proven... It would seem premature to conclude that the MSG present in food causes headache".[91]

Environmental aspects

[edit]

Migraines may be triggered by weather changes, including changes in temperature and barometric pressure.[92][93]

A 2009 review on potential triggers in the indoor and outdoor environment previously concluded that while there were insufficient studies to confirm environmental factors as causing migraine, "migraineurs worldwide consistently report similar environmental triggers ... such as barometric pressure change, bright sunlight, flickering lights, air quality and odors".[94]

Pathophysiology

[edit]
Animation of cortical spreading depression

Migraine is believed to be primarily a neurological disorder,[95][96] while others believe it to be a neurovascular disorder with blood vessels playing the key role, although evidence does not support this completely.[97][98][99][100] Others believe both are likely important.[101][102][103][104] One theory is related to increased excitability of the cerebral cortex and abnormal control of pain neurons in the trigeminal nucleus of the brainstem.[105]

Sensitization of trigeminal pathways is a key pathophysiological phenomenon in migraine. It is debatable whether sensitization starts in the periphery or in the brain.[106][107]

Aura

[edit]

Cortical spreading depression, or spreading depression according to Leão, is a burst of neuronal activity followed by a period of inactivity, which is seen in those with migraine with aura.[108] There are several explanations for its occurrence, including activation of NMDA receptors leading to calcium entering the cell.[108] After the burst of activity, the blood flow to the cerebral cortex in the affected area is decreased for two to six hours.[108] It is believed that when depolarization travels down the underside of the brain, nerves that sense pain in the head and neck are triggered.[108]

Pain

[edit]

The exact mechanism of the head pain which occurs during a migraine episode is unknown.[109] Some evidence supports a primary role for central nervous system structures (such as the brainstem and diencephalon),[110] while other data support the role of peripheral activation (such as via the sensory nerves that surround blood vessels of the head and neck).[109] The potential candidate vessels include dural arteries, pial arteries and extracranial arteries such as those of the scalp.[109] The role of vasodilatation of the extracranial arteries, in particular, is believed to be significant.[111]

Neuromodulators

[edit]

Adenosine, a neuromodulator, may be involved.[112] Released after the progressive cleavage of adenosine triphosphate (ATP), adenosine acts on adenosine receptors to put the body and brain in a low activity state by dilating blood vessels and slowing the heart rate, such as before and during the early stages of sleep. Adenosine levels are high during migraine attacks.[112][113] Caffeine's role as an inhibitor of adenosine may explain its effect in reducing migraine.[114] Low levels of the neurotransmitter serotonin, also known as 5-hydroxytryptamine (5-HT), are also believed to be involved.[115]

Calcitonin gene-related peptides (CGRPs) have been found to play a role in the pathogenesis of the pain associated with migraine, as levels of it become elevated during an attack.[10][42]

Diagnosis

[edit]

The diagnosis of a migraine is based on signs and symptoms.[23] Neuroimaging tests are not necessary to diagnose migraine, but may be used to find other causes of headaches in those whose examination and history do not confirm a migraine diagnosis.[116] It is believed that a substantial number of people with the condition remain undiagnosed.[23]

The diagnosis of migraine without aura, according to the International Headache Society, can be made according to the "5, 4, 3, 2, 1 criteria", which is as follows:[28]

  • Five or more attacks – for migraine with aura, two attacks are sufficient for diagnosis.
  • Four hours to three days in duration
  • Two or more of the following:
    • Unilateral (affecting one side of the head)
    • Pulsating
    • Moderate or severe pain intensity
    • Worsened by or causing avoidance of routine physical activity
  • One or more of the following:

If someone experiences two of the following: photophobia, nausea, or inability to work or study for a day, the diagnosis is more likely.[117] In those with four out of five of the following: pulsating headache, duration of 4–72 hours, pain on one side of the head, nausea, or symptoms that interfere with the person's life, the probability that this is a migraine attack is 92%.[10] In those with fewer than three of these symptoms, the probability is 17%.[10]

Classification

[edit]

Migraine was first comprehensively classified in 1988.[26]

The International Headache Society updated their classification of headaches in 2004.[28] A third version was published in 2018.[118] According to this classification, migraine is a primary headache disorder along with tension-type headaches and cluster headaches, among others.[119]

Migraine is divided into six subclasses (some of which include further subdivisions):[120]

  • Migraine without aura, or "common migraine", involves migraine headaches that are not accompanied by aura.
  • Migraine with aura, or "classic migraine", usually involves migraine headaches accompanied by aura. Less commonly, aura can occur without a headache or with a nonmigraine headache. Two other varieties are familial hemiplegic migraine and sporadic hemiplegic migraine, in which a person has migraine with aura and with accompanying motor weakness. If a close relative has had the same condition, it is called "familial"; otherwise, it is called "sporadic". Another variety is basilar-type migraine, where a headache and aura are accompanied by difficulty speaking, world spinning, ringing in ears, or several other brainstem-related symptoms, but not motor weakness. This type was initially believed to be due to spasms of the basilar artery, the artery that supplies the brainstem. Now that this mechanism is not believed to be primary, the symptomatic term migraine with brainstem aura (MBA) is preferred.[48] Retinal migraine (which is distinct from visual or optical migraine) involves migraine headaches accompanied by visual disturbances or even temporary blindness in one eye.
  • Childhood periodic syndromes that are commonly precursors of migraine include cyclical vomiting (occasional intense periods of vomiting), abdominal migraine (abdominal pain, usually accompanied by nausea), and benign paroxysmal vertigo of childhood (occasional attacks of vertigo).
  • Complications of migraine describe migraine headaches and/or auras that are unusually long or unusually frequent, or associated with a seizure or brain lesion.
  • Probable migraine describes conditions that have some characteristics of migraine, but where there is not enough evidence to diagnose it as migraine with certainty (in the presence of concurrent medication overuse).
  • Chronic migraine is a complication of migraine, and is a headache that fulfills diagnostic criteria for migraine headache and occurs for a greater time interval. Specifically, greater than or equal to 15 days/month for longer than 3 months.[121]

Abdominal migraine

[edit]

The diagnosis of abdominal migraine is controversial.[122] Some evidence indicates that recurrent episodes of abdominal pain in the absence of a headache may be a type of migraine[122][123] or are at least a precursor to migraine attacks.[26] These episodes of pain may or may not follow a migraine-like prodrome and typically last minutes to hours.[122] They often occur in those with either a personal or family history of typical migraine.[122] Other syndromes that are believed to be precursors include cyclical vomiting syndrome and benign paroxysmal vertigo of childhood.[26]

Differential diagnosis

[edit]

Other conditions that can cause similar symptoms to a migraine headache include temporal arteritis, cluster headaches, acute glaucoma, meningitis and subarachnoid hemorrhage.[10] Temporal arteritis typically occurs in people over 50 years old and presents with tenderness over the temple, cluster headache presents with one-sided nose stuffiness, tears and severe pain around the orbits, acute glaucoma is associated with vision problems, meningitis with fevers, and subarachnoid hemorrhage with a very fast onset.[10] Tension headaches typically occur on both sides, are not pounding, and are less disabling.[10]

Those with stable headaches that meet criteria for migraine should not receive neuroimaging to look for other intracranial disease.[124][125][126] This requires that other concerning findings such as papilledema (swelling of the optic disc) are not present. People with migraine are not at an increased risk of having another cause for severe headaches.[citation needed]

Management

[edit]

Management of migraine includes prevention of migraine attacks and rescue treatment. There are three main aspects of treatment: trigger avoidance, acute (abortive), and preventive (prophylactic) control.[127]

Modern approaches to migraine management emphasize personalized care that considers individual patient needs. Lifestyle modifications, such as managing triggers and addressing comorbidities, form the foundation of treatment. Behavioral techniques and supplements like magnesium and riboflavin can serve as supportive options for some individuals.[128] Behavioral techniques that have been utilized in the treatment of migraines include Cognitive Behavioral Therapy (CBT), relaxation training, biofeedback, Acceptance and Commitment Therapy (ACT), as well as mindfulness-based therapies.[129] A 2024 systematic literature review and meta analysis found evidence that treatments such as CBT, relaxation training, ACT, and mindfulness-based therapies can reduce migraine frequency both on their own and in combination with other treatment options.[129] In addition, it was found that relaxation therapy aided in the lessening of migraine frequency when compared to education by itself.[129] Similarly, for children and adolescents, CBT and biofeedback strategies are effective in decreasing of frequency and intensity of migraines. These techniques often include relaxation methods and promotion of long-term management without medication side effects, which is emphasized for younger individuals.[129] Acute treatments, including NSAIDs and triptans, are most effective when administered early in an attack, while preventive medications are recommended for those experiencing frequent or severe migraines. Proven preventive options include beta blockers, topiramate, and CGRP inhibitors like erenumab and galcanezumab, which have demonstrated significant efficacy in clinical studies.[130] The European Consensus Statement provides a framework for diagnosis and management, emphasizing the importance of accurate assessment, patient education, and consistent adherence to prescribed treatments. Innovative therapies of oral medications used to treat migraine symptoms, such as gepants and ditans, are emerging as alternatives for patients who cannot use traditional options.[131]

A 2024 systematic review and network meta analysis compared the effectiveness of medications for acute migraine attacks in adults. It found that triptans were the most effective class of drugs, followed by non-steroidal anti-inflammatories. Gepants were less effective than non-steroidal anti-inflammatory drugs.[132][133]

[edit]

Calcitonin gene-related peptide (CGRP) is a neuropeptide implicated in the pathophysiology of migraines. It is predominantly found in the trigeminal ganglion and central nervous system pathways associated with migraine mechanisms.[134] During migraine attacks, elevated levels of CGRP are detected, leading to vasodilation of cerebral and dural blood vessels and the release of inflammatory mediators from mast cells. These actions contribute to the transmission of nociceptive signals, culminating in migraine pain. Targeting CGRP has emerged as a promising therapeutic strategy for migraine management.[medical citation needed]

Prognosis

[edit]

"Migraine exists on a continuum of different attack frequencies and associated levels of disability."[135] For those with occasional, episodic migraine, a "proper combination of drugs for prevention and treatment of migraine attacks" can limit the disease's impact on patients' personal and professional lives.[136] But fewer than half of people with migraine seek medical care and more than half go undiagnosed and undertreated.[137] "Responsive prevention and treatment of migraine is incredibly important" because evidence shows "an increased sensitivity after each successive attack, eventually leading to chronic daily migraine in some individuals."[136] Repeated migraine results in "reorganization of brain circuitry", causing "profound functional as well as structural changes in the brain."[138] "One of the most important problems in clinical migraine is the progression from an intermittent, self-limited inconvenience to a life-changing disorder of chronic pain, sensory amplification, and autonomic and affective disruption. This progression, sometimes termed chronification in the migraine literature, is common, affecting 3% of migraineurs in a given year, such that 8% of migraineurs have chronic migraine in any given year." Brain imagery reveals that the electrophysiological changes seen during an attack become permanent in people with chronic migraine; "thus, from an electrophysiological point of view, chronic migraine indeed resembles a never-ending migraine attack."[138] Severe migraine ranks in the highest category of disability, according to the World Health Organization, which uses objective metrics to determine disability burden for the authoritative annual Global Burden of Disease report. The report classifies severe migraine alongside severe depression, active psychosis, quadriplegia, and terminal-stage cancer.[139]

Migraine with aura appears to be a risk factor for ischemic stroke[140] doubling the risk.[141] Being a young adult, being female, using hormonal birth control, and smoking further increases this risk.[140] There also appears to be an association with cervical artery dissection.[142] Migraine without aura does not appear to be a factor.[143] The relationship with heart problems is inconclusive with a single study supporting an association.[140] Migraine does not appear to increase the risk of death from stroke or heart disease.[144] Preventative therapy of migraine in those with migraine with aura may prevent associated strokes.[145] People with migraine, particularly women, may develop higher than average numbers of white matter brain lesions of unclear significance.[146]

Epidemiology

[edit]
Percent of women and men who have experienced migraine with or without aura within the last 3 months

Migraine is common, with around 33% of women and 18% of men affected at some point in their lifetime.[147] Onset can be at any age, but prevalence rises sharply around puberty, and remains high until declining after age 50.[147] Before puberty, boys and girls are equally impacted, with around 5% of children experiencing migraine attacks. From puberty onwards, women experience migraine attacks at greater rates than men. From age 30 to 50, up to 4 times as many women experience migraine attacks as men;[147] this is most pronounced in migraine without aura.[148]

Worldwide, migraine affects nearly 15% or approximately one billion people.[19] In the United States, about 6% of men and 18% of women experience a migraine attack in a given year, with a lifetime risk of about 18% and 43%, respectively.[23] In Europe, migraine affects 12–28% of people at some point in their lives, with about 6–15% of adult men and 14–35% of adult women getting at least one attack yearly.[149] Rates of migraine are slightly lower in Asia and Africa than in Western countries.[45][150] Chronic migraine occurs in approximately 1.4–2.2% of the population.[151]

During perimenopause symptoms often get worse before decreasing in severity.[152] While symptoms resolve in about two-thirds of the elderly, in 3–10% they persist.[50]

History

[edit]
The Head Ache, George Cruikshank (1819)

An early description consistent with migraine is contained in the Ebers Papyrus, written around 1500 BCE in ancient Egypt.[153]

The word migraine is from the Greek ἡμικρᾱνίᾱ (hēmikrāníā), 'pain in half of the head',[154] from ἡμι- (hēmi-), 'half' and κρᾱνίον (krāníon), 'skull'.[155]

 

In 200 BCE, writings from the Hippocratic school of medicine described the visual aura that can precede the headache and a partial relief occurring through vomiting.[156]

A second-century description by Aretaeus of Cappadocia divided headaches into three types: cephalalgia, cephalea, and heterocrania.[157] Galen of Pergamon used the term hemicrania (half-head), from which the word migraine was eventually derived.[157] Galen also proposed that the pain arose from the meninges and blood vessels of the head.[156] Migraine was first divided into the two now used types – migraine with aura (migraine ophthalmique) and migraine without aura (migraine vulgaire) in 1887 by Louis Hyacinthe Thomas, a French librarian.[156] The mystical visions of Hildegard von Bingen, which she described as "reflections of the living light", are consistent with the visual aura experienced during migraine attacks.[158]

A trepanated skull, from the Neolithic. The perimeter of the hole in the skull is rounded off by ingrowth of new bony tissue, indicating that the person survived the operation.

Trepanation, the deliberate drilling of holes into a skull, was practiced as early as 7,000 BCE.[153] While sometimes people survived, many would have died from the procedure due to infection.[159] It was believed to work via "letting evil spirits escape".[160] William Harvey recommended trepanation as a treatment for migraine in the 17th century.[161] The association between trepanation and headaches in ancient history may simply be a myth or unfounded speculation that originated several centuries later. In 1913, the world-famous American physician William Osler misinterpreted the French anthropologist and physician Paul Broca's words about a set of children's skulls from the Neolithic age that he found during the 1870s. These skulls presented no evident signs of fractures that could justify this complex surgery for mere medical reasons. Trepanation was probably born of superstitions, to remove "confined demons" inside the head, or to create healing or fortune talismans with the bone fragments removed from the skulls of the patients. However, Osler wanted to make Broca's theory more palatable to his modern audiences, and explained that trepanation procedures were used for mild conditions such as "infantile convulsions headache and various cerebral diseases believed to be caused by confined demons."[162]

While many treatments for migraine have been attempted, it was not until 1868 that use of a substance which eventually turned out to be effective began.[156] This substance was the fungus ergot from which ergotamine was isolated in 1918[163] and first used to treat migraine in 1925.[164] Methysergide was developed in 1959 and the first triptan, sumatriptan, was developed in 1988.[163] During the 20th century, with better study design, effective preventive measures were found and confirmed.[156]

Society and culture

[edit]

Migraine is a significant source of both medical costs and lost productivity. It has been estimated that migraine is the most costly neurological disorder in the European Community, costing more than €27 billion per year.[165] In the United States, direct costs have been estimated at $17 billion, while indirect costs – such as missed or decreased ability to work – is estimated at $15 billion.[166] Nearly a tenth of the direct cost is due to the cost of triptans.[166] In those who do attend work during a migraine attack, effectiveness is decreased by around a third.[165] Negative impacts also frequently occur for a person's family.[165]

Research

[edit]

Prevention mechanisms

[edit]

Transcranial magnetic stimulation shows promise,[10][167] as does transcutaneous supraorbital nerve stimulation.[168] There is preliminary evidence that a ketogenic diet may help prevent episodic and long-term migraine.[169][170]

Sex dependency

[edit]

Statistical data indicates that women may be more prone to having migraine, showing migraine incidence three times higher among women than men.[171][172] The Society for Women's Health Research has also mentioned hormonal influences, mainly estrogen, as having a considerable role in provoking migraine pain. Studies and research related to the sex dependencies of migraine are ongoing, and conclusions have yet to be achieved.[173]

 

See also

[edit]

References

[edit]
  1. ^ Wells JC (2008). Longman Pronunciation Dictionary (3rd ed.). Longman. ISBN 978-1-4058-8118-0.
  2. ^ Jones D (2011). Roach P, Setter J, Esling J (eds.). Cambridge English Pronouncing Dictionary (18th ed.). Cambridge University Press. ISBN 978-0-521-15255-6.
  3. ^ a b Pescador Ruschel MA, De Jesus O (2024). "Migraine Headache". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32809622. Retrieved 13 September 2024.
  4. ^ a b "Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition". Cephalalgia: An International Journal of Headache. 38 (1): 1–211. January 2018. doi:10.1177/0333102417738202. ISSN 1468-2982. PMID 29368949.
  5. ^ Martins IP, Gouveia RG, Parreira E (June 2006). "Kinesiophobia in migraine". The Journal of Pain. 7 (6): 445–451. doi:10.1016/j.jpain.2006.01.449. PMID 16750801.
  6. ^ a b Katsarava Z, Buse DC, Manack AN, Lipton RB (February 2012). "Defining the differences between episodic migraine and chronic migraine". Current Pain and Headache Reports. 16 (1): 86–92. doi:10.1007/s11916-011-0233-z. PMC 3258393. PMID 22083262.
  7. ^ Shankar Kikkeri N, Nagalli S (December 2022). "Migraine With Aura". StatPearls Publishing. PMID 32119498. Bookshelf ID: NBK554611. Archived from the original on 8 June 2023. Retrieved 23 August 2023.
  8. ^ a b c Piane M, Lulli P, Farinelli I, Simeoni S, De Filippis S, Patacchioli FR, et al. (December 2007). "Genetics of migraine and pharmacogenomics: some considerations". The Journal of Headache and Pain. 8 (6): 334–339. doi:10.1007/s10194-007-0427-2. PMC 2779399. PMID 18058067.
  9. ^ Burstein R, Noseda R, Borsook D (April 2015). "Migraine: multiple processes, complex pathophysiology". The Journal of Neuroscience. 35 (17): 6619–6629. doi:10.1523/JNEUROSCI.0373-15.2015. PMC 4412887. PMID 25926442.
  10. ^ a b c d e f g h i Gilmore B, Michael M (February 2011). "Treatment of acute migraine headache". American Family Physician. 83 (3): 271–280. PMID 21302868.
  11. ^ Tzankova V, Becker WJ, Chan TL (January 2023). "Diagnosis and acute management of migraine". CMAJ. 195 (4): E153 – E158. doi:10.1503/cmaj.211969. PMC 9888545. PMID 36717129. Archived from the original on 4 July 2023. Retrieved 22 August 2023.
  12. ^ Silberstein SD (August 2015). "Preventive Migraine Treatment". Continuum. 21 (4 Headache): 973–989. doi:10.1212/CON.0000000000000199. PMC 4640499. PMID 26252585.
  13. ^ Kumar A, Kadian R (September 2022). "Migraine Prophylaxis". StatPearls Publishing. PMID 29939650. Bookshelf ID: NBK507873. Archived from the original on 8 March 2023. Retrieved 22 August 2023.
  14. ^ Noseda R, Burstein R (December 2013). "Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain". Pain. 154 (Suppl 1): S44 – S53. doi:10.1016/j.pain.2013.07.021. PMC 3858400. PMID 24347803.
  15. ^ Spierings EL (July 2001). "Mechanism of migraine and action of antimigraine medications". The Medical Clinics of North America. 85 (4): 943–958, vi–vii. doi:10.1016/s0025-7125(05)70352-7. PMID 11480266. Archived from the original on 1 March 2023. Retrieved 22 August 2023.
  16. ^ Haghdoost F, Togha M (1 January 2022). "Migraine management: Non-pharmacological points for patients and health care professionals". Open Medicine. 17 (1): 1869–1882. doi:10.1515/med-2022-0598. PMC 9691984. PMID 36475060.
  17. ^ Office of the Commissioner (24 March 2020). "FDA approves novel preventive treatment for migraine". FDA. Archived from the original on 11 June 2019. Retrieved 13 September 2024.
  18. ^ Rashid A, Manghi A (2024). "Calcitonin Gene-Related Peptide Receptor". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32809483. Retrieved 13 September 2024.
  19. ^ a b Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. (December 2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMC 6350784. PMID 23245607.
  20. ^ Gobel H. "1. Migraine". ICHD-3 The International Classification of Headache Disorders 3rd edition. Archived from the original on 24 October 2020. Retrieved 22 October 2020.
  21. ^ "Headache disorders Fact sheet N°277". October 2012. Archived from the original on 16 February 2016. Retrieved 15 February 2016.
  22. ^ Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. (GBD 2016 Disease and Injury Incidence and Prevalence Collaborators) (September 2017). "Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016". Lancet. 390 (10100): 1211–1259. doi:10.1016/S0140-6736(17)32154-2. PMC 5605509. PMID 28919117.
  23. ^ a b c d e f g h Bartleson JD, Cutrer FM (May 2010). "Migraine update. Diagnosis and treatment". Minnesota Medicine. 93 (5): 36–41. PMID 20572569.
  24. ^ Bigal ME, Lipton RB (June 2008). "The prognosis of migraine". Current Opinion in Neurology. 21 (3): 301–8. doi:10.1097/WCO.0b013e328300c6f5. PMID 18451714. S2CID 34805084.
  25. ^ Gutman SA (2008). Quick reference neuroscience for rehabilitation professionals: the essential neurologic principles underlying rehabilitation practice (2nd ed.). Thorofare, NJ: SLACK. p. 231. ISBN 9781556428005. Archived from the original on 12 March 2017.
  26. ^ a b c d e Olesen J, Goadsby PJ (2006). "The Migraines: Introduction". In Olesen J (ed.). The Headaches (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 232–233. ISBN 978-0-7817-5400-2. Archived from the original on 13 March 2017.
  27. ^ Tfelt-Hansen P, Young WB, Silberstein (2006). "Antiemetic, Prokinetic, Neuroleptic and Miscellaneous Drugs in the Acute Treatment of Migraine". In Olesen J (ed.). The Headaches (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. p. 512. ISBN 978-0-7817-5400-2. Archived from the original on 22 December 2016.
  28. ^ a b c d Headache Classification Subcommittee of the International Headache Society (2013). "The International Classification of Headache Disorders: 3rd edition". Cephalalgia. 33 (9): 644–648. doi:10.1177/0333102413485658. PMID 23771276.
  29. ^ Baskin SM, Lipchik GL, Smitherman TA (October 2006). "Mood and anxiety disorders in chronic headache". Headache. 46 (Suppl 3): S76-87. doi:10.1111/j.1526-4610.2006.00559.x. PMID 17034402. S2CID 35451906.
  30. ^ a b c d e f g h i Simon RP, Aminoff MJ, Greenberg DA (2009). Clinical neurology (7 ed.). New York, N.Y: Lange Medical Books/McGraw-Hill. pp. 85–88. ISBN 9780071664332.
  31. ^ a b Lynn DJ, Newton HB, Rae-Grant A (2004). The 5-minute neurology consult. Philadelphia: Lippincott Williams & Wilkins. p. 26. ISBN 9780683307238. Archived from the original on 13 March 2017.
  32. ^ Buzzi MG, Cologno D, Formisano R, Rossi P (October–December 2005). "Prodromes and the early phase of the migraine attack: therapeutic relevance". Functional Neurology. 20 (4): 179–83. PMID 16483458.
  33. ^ Rossi P, Ambrosini A, Buzzi MG (October–December 2005). "Prodromes and predictors of migraine attack". Functional Neurology. 20 (4): 185–91. PMID 16483459.
  34. ^ Ropper AH, Adams RD, Victor M, Samuels MA (2009). Adams and Victor's principles of neurology (9 ed.). New York: McGraw-Hill Medical. pp. Chapter 10. ISBN 9780071499927.
  35. ^ May A, Burstein R (November 2019). "Hypothalamic regulation of headache and migraine". Cephalalgia. 39 (13): 1710–1719. doi:10.1177/0333102419867280. PMC 7164212. PMID 31466456.
  36. ^ a b c d Tintinalli JE (2010). Emergency Medicine: A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies. pp. 1116–1117. ISBN 978-0-07-148480-0.
  37. ^ Ashina M (November 2020). "Migraine". The New England Journal of Medicine. 383 (19): 1866–1876. doi:10.1056/NEJMra1915327. PMID 33211930. S2CID 227078662.
  38. ^ a b c d e f g h i j k Cutrer FM, Olesen J (2006). "Migraines with Aura and Their Subforms". In Olesen J (ed.). The Headaches (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 238–240. ISBN 978-0-7817-5400-2. Archived from the original on 13 March 2017.
  39. ^ Viana M, Sances G, Linde M, Nappi G, Khaliq F, Goadsby PJ, et al. (August 2018). "Prolonged migraine aura: new insights from a prospective diary-aided study". The Journal of Headache and Pain. 19 (1): 77. doi:10.1186/s10194-018-0910-y. PMC 6119171. PMID 30171359.
  40. ^ Slap, GB (2008). Adolescent medicine. Philadelphia, PA: Mosby/Elsevier. p. 105. ISBN 9780323040730. Archived from the original on 13 March 2017.
  41. ^ Amin FM, Aristeidou S, Baraldi C, Czapinska-Ciepiela EK, Ariadni DD, Di Lenola D, et al. (September 2018). "The association between migraine and physical exercise". The Journal of Headache and Pain. 19 (1): 83. doi:10.1186/s10194-018-0902-y. PMC 6134860. PMID 30203180.
  42. ^ a b Qubty W, Patniyot I (June 2020). "Migraine Pathophysiology". Pediatric Neurology. 107: 1–6. doi:10.1016/j.pediatrneurol.2019.12.014. PMID 32192818. S2CID 213191464.
  43. ^ Tepper SJ, Tepper DE (1 January 2011). The Cleveland Clinic manual of headache therapy. New York: Springer. p. 6. ISBN 9781461401780. Archived from the original on 22 December 2016.
  44. ^ Bigal ME, Arruda MA (July 2010). "Migraine in the pediatric population--evolving concepts". Headache. 50 (7): 1130–43. doi:10.1111/j.1526-4610.2010.01717.x. PMID 20572878. S2CID 23256755.
  45. ^ a b c d Rasmussen BK (2006). "Epidemiology of Migraine". In Olesen J (ed.). The Headaches (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 238–240. ISBN 978-0-7817-5400-2. Archived from the original on 13 March 2017.
  46. ^ Dalessio DJ (2001). Silberstein SD, Lipton RB, Dalessio DJ (eds.). Wolff's headache and other head pain (7 ed.). Oxford: Oxford University Press. p. 122. ISBN 9780195135183.
  47. ^ a b Lisak RP, Truong DD, Carroll W, Bhidayasiri R (2009). International neurology: a clinical approach. Chichester, UK: Wiley-Blackwell. p. 670. ISBN 9781405157384.
  48. ^ a b Kaniecki RG (June 2009). "Basilar-type migraine". Current Pain and Headache Reports. 13 (3): 217–20. doi:10.1007/s11916-009-0036-7. PMID 19457282. S2CID 22242504.
  49. ^ a b Glaser JS (1999). Neuro-ophthalmology (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. p. 555. ISBN 9780781717298. Archived from the original on 13 March 2017.
  50. ^ a b Dodick DW, Capobianco DJ (2008). "Chapter 14: Headaches". In Sirven JI, Malamut BL (eds.). Clinical neurology of the older adult (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 197. ISBN 9780781769471. Archived from the original on 12 March 2017.
  51. ^ Robblee J (21 August 2019). "Silent Migraine: A Guide". American Migraine Foundation. Archived from the original on 28 January 2021. Retrieved 22 January 2021.
  52. ^ He Y, Li Y, Nie Z (February 2015). "Typical aura without headache: a case report and review of the literature". Journal of Medical Case Reports. 9 (1): 40. doi:10.1186/s13256-014-0510-7. PMC 4344793. PMID 25884682.
  53. ^ Leonard J (7 September 2018). Han S (ed.). "Silent migraine: Symptoms, causes, treatment, prevention". Medical News Today. Archived from the original on 19 January 2021. Retrieved 22 January 2021.
  54. ^ Bose P, Goadsby PJ (June 2016). "The migraine postdrome". Current Opinion in Neurology. 29 (3): 299–301. doi:10.1097/WCO.0000000000000310. PMID 26886356. S2CID 22445093.
  55. ^ Kelman L (February 2006). "The postdrome of the acute migraine attack". Cephalalgia. 26 (2): 214–20. doi:10.1111/j.1468-2982.2005.01026.x. PMID 16426278. S2CID 21519111.
  56. ^ Halpern AL, Silberstein SD (2005). "Ch. 9: The Migraine Attack—A Clinical Description". In Kaplan PW, Fisher RS (eds.). Imitators of Epilepsy (2 ed.). New York: Demos Medical. ISBN 978-1-888799-83-5. NBK7326. Archived from the original on 27 August 2011. Retrieved 5 September 2017.
  57. ^ Robbins MS, Lipton RB (April 2010). "The epidemiology of primary headache disorders". Seminars in Neurology. 30 (2): 107–19. doi:10.1055/s-0030-1249220. PMID 20352581. S2CID 260317083.
  58. ^ a b c Schürks M (January 2012). "Genetics of migraine in the age of genome-wide association studies". The Journal of Headache and Pain. 13 (1): 1–9. doi:10.1007/s10194-011-0399-0. PMC 3253157. PMID 22072275.
  59. ^ The Headaches, pp. 246–247
  60. ^ Bink T, Duraku LS, Ter Louw RP, Zuidam JM, Mathijssen IM, Driessen C (December 2019). "The Cutting Edge of Headache Surgery: A Systematic Review on the Value of Extracranial Surgery in the Treatment of Chronic Headache". Plastic and Reconstructive Surgery. 144 (6): 1431–1448. doi:10.1097/PRS.0000000000006270. PMID 31764666. S2CID 208273535.
  61. ^ Szmyd B, Sołek J, Błaszczyk M, Jankowski J, Liberski PP, Jaskólski DJ, et al. (4 July 2022). "The Underlying Pathogenesis of Neurovascular Compression Syndromes: A Systematic Review". Frontiers in Molecular Neuroscience. 15: 923089. doi:10.3389/fnmol.2022.923089. PMC 9289473. PMID 35860499.
  62. ^ Macionis V (November 2023). "Neurovascular Compression-Induced Intracranial Allodynia May Be the True Nature of Migraine Headache: an Interpretative Review". Current Pain and Headache Reports. 27 (11): 775–791. doi:10.1007/s11916-023-01174-7. PMID 37837483.
  63. ^ Adair D, Truong D, Esmaeilpour Z, Gebodh N, Borges H, Ho L, et al. (May 2020). "Electrical stimulation of cranial nerves in cognition and disease". Brain Stimulation. 13 (3): 717–750. doi:10.1016/j.brs.2020.02.019. PMC 7196013. PMID 32289703.
  64. ^ Villar-Martinez MD, Goadsby PJ (September 2022). "Pathophysiology and Therapy of Associated Features of Migraine". Cells. 11 (17): 2767. doi:10.3390/cells11172767. PMC 9455236. PMID 36078174.
  65. ^ Gormley P, Kurki MI, Hiekkala ME, Veerapen K, Häppölä P, Mitchell AA, et al. (May 2018). "Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families". Neuron. 98 (4): 743–753.e4. doi:10.1016/j.neuron.2018.04.014. PMC 5967411. PMID 29731251.
  66. ^ Harder AV, Terwindt GM, Nyholt DR, van den Maagdenberg AM (February 2023). "Migraine genetics: Status and road forward". Cephalalgia. 43 (2): 3331024221145962. doi:10.1177/03331024221145962. PMID 36759319.
  67. ^ de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM (July 2009). "Molecular genetics of migraine". Human Genetics. 126 (1): 115–32. doi:10.1007/s00439-009-0684-z. PMID 19455354. S2CID 20119237.
  68. ^ Montagna P (September 2008). "Migraine genetics". Expert Review of Neurotherapeutics. 8 (9): 1321–30. doi:10.1586/14737175.8.9.1321. PMID 18759544. S2CID 207195127.
  69. ^ a b c Ducros A (May 2013). "[Genetics of migraine]". Revue Neurologique. 169 (5): 360–71. doi:10.1016/j.neurol.2012.11.010. PMID 23618705.
  70. ^ Wan D, Wang C, Zhang X, Tang W, Chen M, Dong Z, et al. (1 January 2016). "Association between angiotensin-converting enzyme insertion/deletion polymorphism and migraine: a meta-analysis". The International Journal of Neuroscience. 126 (5): 393–9. doi:10.3109/00207454.2015.1025395. PMID 26000817. S2CID 34902092.
  71. ^ Dussor G, Cao YQ (October 2016). "TRPM8 and Migraine". Headache. 56 (9): 1406–1417. doi:10.1111/head.12948. PMC 5335856. PMID 27634619.
  72. ^ Bjornsdottir G, Chalmer MA, Stefansdottir L, Skuladottir AT, Einarsson G, Andresdottir M, et al. (November 2023). "Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura". Nature Genetics. 55 (11): 1843–1853. doi:10.1038/s41588-023-01538-0. PMC 10632135. PMID 37884687.
  73. ^ Hautakangas H, Winsvold BS, Ruotsalainen SE, Bjornsdottir G, Harder AV, Kogelman LJ, et al. (February 2022). "Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles". Nature Genetics. 54 (2): 152–160. doi:10.1038/s41588-021-00990-0. PMC 8837554. PMID 35115687.
  74. ^ Mikol DD, Picard H, Klatt J, Wang A, Peng C, Stefansson K (14 April 2020). "Migraine Polygenic Risk Score Is Associated with Severity of Migraine – Analysis of Genotypic Data from Four Placebo-controlled Trials of Erenumab (1214)". Neurology. 94 (15_supplement). doi:10.1212/WNL.94.15_supplement.1214. ISSN 0028-3878.
  75. ^ Kogelman LJ, Esserlind AL, Francke Christensen A, Awasthi S, Ripke S, Ingason A, et al. (December 2019). "Migraine polygenic risk score associates with efficacy of migraine-specific drugs". Neurology. Genetics. 5 (6): e364. doi:10.1212/NXG.0000000000000364. PMC 6878840. PMID 31872049.
  76. ^ a b c Levy D, Strassman AM, Burstein R (June 2009). "A critical view on the role of migraine triggers in the genesis of migraine pain". Headache. 49 (6): 953–7. doi:10.1111/j.1526-4610.2009.01444.x. PMID 19545256. S2CID 31707887.
  77. ^ Martin PR (June 2010). "Behavioral management of migraine headache triggers: learning to cope with triggers". Current Pain and Headache Reports. 14 (3): 221–7. doi:10.1007/s11916-010-0112-z. PMID 20425190. S2CID 5511782.
  78. ^ Pavlovic JM, Buse DC, Sollars CM, Haut S, Lipton RB (2014). "Trigger factors and premonitory features of migraine attacks: summary of studies". Headache. 54 (10): 1670–9. doi:10.1111/head.12468. PMID 25399858. S2CID 25016889.
  79. ^ Stanyer EC, Creeney H, Nesbitt AD, Holland PR, Hoffmann J (October 2021). "Subjective Sleep Quality and Sleep Architecture in Patients With Migraine: A Meta-analysis". Neurology. 97 (16): e1620 – e1631. doi:10.1212/WNL.0000000000012701. PMC 8548957. PMID 34551985.
  80. ^ a b Radat F (May 2013). "[Stress and migraine]". Revue Neurologique. 169 (5): 406–12. doi:10.1016/j.neurol.2012.11.008. PMID 23608071.
  81. ^ Peterlin BL, Katsnelson MJ, Calhoun AH (October 2009). "The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen". Current Pain and Headache Reports. 13 (5): 404–12. doi:10.1007/s11916-009-0066-1. PMC 3972495. PMID 19728969.
  82. ^ Chai NC, Peterlin BL, Calhoun AH (June 2014). "Migraine and estrogen". Current Opinion in Neurology. 27 (3): 315–24. doi:10.1097/WCO.0000000000000091. PMC 4102139. PMID 24792340.
  83. ^ Finocchi C, Sivori G (May 2012). "Food as trigger and aggravating factor of migraine". Neurological Sciences. 33 (Suppl 1): S77-80. doi:10.1007/s10072-012-1046-5. PMID 22644176. S2CID 19582697.
  84. ^ Rockett FC, de Oliveira VR, Castro K, Chaves ML, Perla A, Perry ID (June 2012). "Dietary aspects of migraine trigger factors". Nutrition Reviews. 70 (6): 337–56. doi:10.1111/j.1753-4887.2012.00468.x. PMID 22646127.
  85. ^ Ghose K, Carroll JD (1984). "Mechanism of tyramine-induced migraine: similarity with dopamine and interactions with disulfiram and propranolol in migraine patients". Neuropsychobiology. 12 (2–3): 122–126. doi:10.1159/000118123. PMID 6527752.
  86. ^ Moffett A, Swash M, Scott DF (August 1972). "Effect of tyramine in migraine: a double-blind study". Journal of Neurology, Neurosurgery, and Psychiatry. 35 (4): 496–499. doi:10.1136/jnnp.35.4.496. PMC 494110. PMID 4559027.
  87. ^ "Tyramine and Migraines: What You Need to Know". excedrin.com. Retrieved 4 March 2022.
  88. ^ Encyclopedia of Food Sciences and Nutrition (Second ed.). Academic Press. 2003. ISBN 978-0-12-227055-0.
  89. ^ Özturan A, Şanlıer N, Coşkun Ö (2016). "The Relationship Between Migraine and Nutrition" (PDF). Turk J Neurol. 22 (2): 44–50. doi:10.4274/tnd.37132. Archived (PDF) from the original on 23 August 2023. Retrieved 4 March 2022.
  90. ^ Sun-Edelstein C, Mauskop A (June 2009). "Foods and supplements in the management of migraine headaches" (PDF). The Clinical Journal of Pain. 25 (5): 446–452. CiteSeerX 10.1.1.530.1223. doi:10.1097/AJP.0b013e31819a6f65. PMID 19454881. S2CID 3042635. Archived from the original (PDF) on 13 August 2017.
  91. ^ Obayashi Y, Nagamura Y (17 May 2016). "Does monosodium glutamate really cause headache? : a systematic review of human studies". The Journal of Headache and Pain. 17 (1): 54. doi:10.1186/s10194-016-0639-4. PMC 4870486. PMID 27189588.
  92. ^ "Why Climate Change Might Be Affecting Your Headaches". www.pennmedicine.org.
  93. ^ Cioffi I, Farella M, Chiodini P, Ammendola L, Capuozzo R, Klain C, et al. (May 2017). "Effect of weather on temporal pain patterns in patients with temporomandibular disorders and migraine". Journal of Oral Rehabilitation. pp. 333–339. doi:10.1111/joor.12498.
  94. ^ Friedman DI, De ver Dye T (June 2009). "Migraine and the environment". Headache. 49 (6): 941–52. doi:10.1111/j.1526-4610.2009.01443.x. PMID 19545255. S2CID 29764274.
  95. ^ Andreou AP, Edvinsson L (December 2019). "Mechanisms of migraine as a chronic evolutive condition". The Journal of Headache and Pain. 20 (1): 117. doi:10.1186/s10194-019-1066-0. PMC 6929435. PMID 31870279.
  96. ^ "Migraine". National Institute of Neurological Disorders and Stroke. 11 July 2023. Retrieved 25 August 2023.
  97. ^ Hoffmann J, Baca SM, Akerman S (April 2019). "Neurovascular mechanisms of migraine and cluster headache". Journal of Cerebral Blood Flow and Metabolism. 39 (4): 573–594. doi:10.1177/0271678x17733655. PMC 6446418. PMID 28948863.
  98. ^ Brennan KC, Charles A (June 2010). "An update on the blood vessel in migraine". Current Opinion in Neurology. 23 (3): 266–74. doi:10.1097/WCO.0b013e32833821c1. PMC 5500293. PMID 20216215.
  99. ^ Spiri D, Titomanlio L, Pogliani L, Zuccotti G (January 2012). "Pathophysiology of migraine: The neurovascular theory". Headaches: Causes, Treatment and Prevention: 51–64.
  100. ^ Goadsby PJ (January 2009). "The vascular theory of migraine--a great story wrecked by the facts". Brain. 132 (Pt 1): 6–7. doi:10.1093/brain/awn321. PMID 19098031.
  101. ^ Dodick DW (April 2008). "Examining the essence of migraine--is it the blood vessel or the brain? A debate". Headache. 48 (4): 661–7. doi:10.1111/j.1526-4610.2008.01079.x. PMID 18377395. S2CID 6272233.
  102. ^ Chen D, Willis-Parker M, Lundberg GP (October 2020). "Migraine headache: Is it only a neurological disorder? Links between migraine and cardiovascular disorders". Trends in Cardiovascular Medicine. 30 (7): 424–430. doi:10.1016/j.tcm.2019.10.005. PMID 31679956.
  103. ^ Jacobs B, Dussor G (December 2016). "Neurovascular contributions to migraine: Moving beyond vasodilation". Neuroscience. 338: 130–144. doi:10.1016/j.neuroscience.2016.06.012. PMC 5083225. PMID 27312704.
  104. ^ Mason BN, Russo AF (2018). "Vascular Contributions to Migraine: Time to Revisit?". Frontiers in Cellular Neuroscience. 12: 233. doi:10.3389/fncel.2018.00233. PMC 6088188. PMID 30127722.
  105. ^ Dodick DW, Gargus JJ (August 2008). "Why migraines strike". Scientific American. 299 (2): 56–63. Bibcode:2008SciAm.299b..56D. doi:10.1038/scientificamerican0808-56. PMID 18666680.
  106. ^ Edvinsson L, Haanes KA (May 2020). "Views on migraine pathophysiology: Where does it start?". Neurology and Clinical Neuroscience. 8 (3): 120–127. doi:10.1111/ncn3.12356. ISSN 2049-4173. S2CID 214320892.
  107. ^ Do TP, Hougaard A, Dussor G, Brennan KC, Amin FM (January 2023). "Migraine attacks are of peripheral origin: the debate goes on". The Journal of Headache and Pain. 24 (1): 3. doi:10.1186/s10194-022-01538-1. PMC 9830833. PMID 36627561.
  108. ^ a b c d The Headaches, Chp. 28, pp. 269–72
  109. ^ a b c Olesen J, Burstein R, Ashina M, Tfelt-Hansen P (July 2009). "Origin of pain in migraine: evidence for peripheral sensitisation". The Lancet. Neurology. 8 (7): 679–90. doi:10.1016/S1474-4422(09)70090-0. PMID 19539239. S2CID 20452008.
  110. ^ Akerman S, Holland PR, Goadsby PJ (September 2011). "Diencephalic and brainstem mechanisms in migraine". Nature Reviews. Neuroscience. 12 (10): 570–84. doi:10.1038/nrn3057. PMID 21931334. S2CID 8472711.
  111. ^ Shevel E (March 2011). "The extracranial vascular theory of migraine--a great story confirmed by the facts". Headache. 51 (3): 409–417. doi:10.1111/j.1526-4610.2011.01844.x. PMID 21352215. S2CID 6939786.
  112. ^ a b Burnstock G (January 2016). "Purinergic Mechanisms and Pain". In Barrett JE (ed.). Pharmacological Mechanisms and the Modulation of Pain. Advances in Pharmacology. Vol. 75. pp. 91–137. doi:10.1016/bs.apha.2015.09.001. ISBN 9780128038833. PMID 26920010.
  113. ^ Davidoff R (14 February 2002). Migraine: Manifestations, Pathogenesis, and Management. Oxford University Press. ISBN 978-0-19-803135-2. Archived from the original on 23 August 2023. Retrieved 12 November 2020.
  114. ^ Lipton RB, Diener HC, Robbins MS, Garas SY, Patel K (October 2017). "Caffeine in the management of patients with headache". The Journal of Headache and Pain. 18 (1): 107. doi:10.1186/s10194-017-0806-2. PMC 5655397. PMID 29067618.
  115. ^ Hamel E (November 2007). "Serotonin and migraine: biology and clinical implications". Cephalalgia. 27 (11): 1293–300. doi:10.1111/j.1468-2982.2007.01476.x. PMID 17970989. S2CID 26543041.
  116. ^
  117. ^ Cousins G, Hijazze S, Van de Laar FA, Fahey T (July–August 2011). "Diagnostic accuracy of the ID Migraine: a systematic review and meta-analysis". Headache. 51 (7): 1140–8. doi:10.1111/j.1526-4610.2011.01916.x. PMID 21649653. S2CID 205684294.
  118. ^ "Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition". Cephalalgia. 38 (1): 1–211. January 2018. doi:10.1177/0333102417738202. PMID 29368949.
  119. ^ Nappi G (September 2005). "Introduction to the new International Classification of Headache Disorders". The Journal of Headache and Pain. 6 (4): 203–4. doi:10.1007/s10194-005-0185-y. PMC 3452009. PMID 16362664.
  120. ^ "Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition". Cephalalgia. 38 (1): 1–211. January 2018. doi:10.1177/0333102417738202. ISSN 0333-1024. PMID 29368949.
  121. ^ Negro A, Rocchietti-March M, Fiorillo M, Martelletti P (December 2011). "Chronic migraine: current concepts and ongoing treatments". European Review for Medical and Pharmacological Sciences. 15 (12): 1401–20. PMID 22288302.
  122. ^ a b c d Davidoff RA (2002). Migraine : manifestations, pathogenesis, and management (2 ed.). Oxford [u.a.]: Oxford Univ. Press. p. 81. ISBN 9780195137057. Archived from the original on 22 December 2016.
  123. ^ Russell G, Abu-Arafeh I, Symon DN (2002). "Abdominal migraine: evidence for existence and treatment options". Paediatric Drugs. 4 (1): 1–8. doi:10.2165/00128072-200204010-00001. PMID 11817981. S2CID 12289726.
  124. ^ Lewis DW, Dorbad D (September 2000). "The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations". Headache. 40 (8): 629–32. doi:10.1046/j.1526-4610.2000.040008629.x. PMID 10971658. S2CID 14443890.
  125. ^ Silberstein SD (September 2000). "Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 55 (6): 754–62. doi:10.1212/WNL.55.6.754. PMID 10993991.
  126. ^ Medical Advisory Secretariat (2010). "Neuroimaging for the evaluation of chronic headaches: an evidence-based analysis". Ontario Health Technology Assessment Series. 10 (26): 1–57. PMC 3377587. PMID 23074404.
  127. ^ Chawla J, Lutsep HL (13 June 2023). "Migraine Headache Treatment & Management". Medscape. Retrieved 3 May 2024.
  128. ^ Jenkins, B. Migraine management. Australian Prescriber. 2020; 43(5):148–151. https://doi.org/10.18773/austprescr.2020.047
  129. ^ a b c d Treadwell JR, Tsou AY, Rouse B, Ivlev I, Fricke J, Buse D, et al. (2024). Behavioral Interventions for Migraine Prevention (Report). Agency for Healthcare Research and Quality (AHRQ). doi:10.23970/ahrqepccer270. PMID 39471258.
  130. ^ Mohanty D, Lippmann S (April 2020). "CGRP Inhibitors for Migraine". Innovations in Clinical Neuroscience. 17 (4–6): 39–40. PMC 7413335. PMID 32802591.
  131. ^ Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, et al. (August 2021). "Diagnosis and management of migraine in ten steps". Nature Reviews. Neurology. 17 (8): 501–514. doi:10.1038/s41582-021-00509-5. PMC 8321897. PMID 34145431.
  132. ^ Karlsson WK, Ostinelli EG, Zhuang ZA, Kokoti L, Christensen RH, Al-Khazali HM, et al. (18 September 2024). "Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis". BMJ. 386: e080107. doi:10.1136/bmj-2024-080107. ISSN 1756-1833. PMC 11409395. PMID 39293828.
  133. ^ "Which drugs are best for migraine attacks?". NIHR Evidence. 4 March 2025.
  134. ^ Wattiez AS, Sowers LP, Russo AF (February 2020). "Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting". Expert Opinion on Therapeutic Targets. 24 (2): 91–100. doi:10.1080/14728222.2020.1724285. PMC 7050542. PMID 32003253.
  135. ^ Silberstein SD, Lee L, Gandhi K, Fitzgerald T, Bell J, Cohen JM (November 2018). "Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine". Headache. 58 (10): 1579–1592. doi:10.1111/head.13421. PMID 30375650. S2CID 53114546.
  136. ^ a b "Migraine Information Page: Prognosis". National Institute for Neurological Disorders and Stroke (NINDS). National Institutes of Health (US). Archived from the original on 10 June 2020.
  137. ^ "Key facts and figures about migraine". The Migraine Trust. 2017. Archived from the original on 12 March 2017. Retrieved 13 June 2021.
  138. ^ a b Brennan KC, Pietrobon D (March 2018). "A Systems Neuroscience Approach to Migraine". Neuron. 97 (5): 1004–1021. doi:10.1016/j.neuron.2018.01.029. PMC 6402597. PMID 29518355.
  139. ^ "The Global Burden of Disease: 2004 Update" (PDF). World Health Organization. 2008. p. 33. Archived from the original (PDF) on 13 June 2021. Disability classes for the Global Burden of Disease study (table 8)
  140. ^ a b c Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (October 2009). "Migraine and cardiovascular disease: systematic review and meta-analysis". BMJ. 339: b3914. doi:10.1136/bmj.b3914. PMC 2768778. PMID 19861375.
  141. ^ Kurth T, Chabriat H, Bousser MG (January 2012). "Migraine and stroke: a complex association with clinical implications". The Lancet. Neurology. 11 (1): 92–100. doi:10.1016/S1474-4422(11)70266-6. PMID 22172624. S2CID 31939284.
  142. ^ Rist PM, Diener HC, Kurth T, Schürks M (June 2011). "Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis". Cephalalgia. 31 (8): 886–96. doi:10.1177/0333102411401634. PMC 3303220. PMID 21511950.
  143. ^ Kurth T (March 2010). "The association of migraine with ischemic stroke". Current Neurology and Neuroscience Reports. 10 (2): 133–9. doi:10.1007/s11910-010-0098-2. PMID 20425238. S2CID 27227332.
  144. ^ Schürks M, Rist PM, Shapiro RE, Kurth T (September 2011). "Migraine and mortality: a systematic review and meta-analysis". Cephalalgia. 31 (12): 1301–14. doi:10.1177/0333102411415879. PMC 3175288. PMID 21803936.
  145. ^ Weinberger J (March 2007). "Stroke and migraine". Current Cardiology Reports. 9 (1): 13–9. doi:10.1007/s11886-007-0004-y. PMID 17362679. S2CID 46681674.
  146. ^ Hougaard A, Amin FM, Ashina M (June 2014). "Migraine and structural abnormalities in the brain". Current Opinion in Neurology. 27 (3): 309–14. doi:10.1097/wco.0000000000000086. PMID 24751961.
  147. ^ a b c Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, et al. (January 2022). "Migraine". Nature Reviews. Disease Primers. 8 (1): 2. doi:10.1038/s41572-021-00328-4. PMID 35027572. S2CID 245883895.
  148. ^ Chalmer MA, Kogelman LJ, Callesen I, Christensen CG, Techlo TR, Møller PL, et al. (June 2023). "Sex differences in clinical characteristics of migraine and its burden: a population-based study". European Journal of Neurology. 30 (6): 1774–1784. doi:10.1111/ene.15778. PMID 36905094.
  149. ^ Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J (April 2006). "Epidemiology of headache in Europe". European Journal of Neurology. 13 (4): 333–45. doi:10.1111/j.1468-1331.2006.01184.x. PMID 16643310. S2CID 7490176.
  150. ^ Wang SJ (March 2003). "Epidemiology of migraine and other types of headache in Asia". Current Neurology and Neuroscience Reports. 3 (2): 104–8. doi:10.1007/s11910-003-0060-7. PMID 12583837. S2CID 24939546.
  151. ^ Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, et al. (May 2010). "Global prevalence of chronic migraine: a systematic review". Cephalalgia. 30 (5): 599–609. doi:10.1111/j.1468-2982.2009.01941.x. PMID 19614702. S2CID 5328642.
  152. ^ Nappi RE, Sances G, Detaddei S, Ornati A, Chiovato L, Polatti F (June 2009). "Hormonal management of migraine at menopause". Menopause International. 15 (2): 82–6. doi:10.1258/mi.2009.009022. PMID 19465675. S2CID 23204921.
  153. ^ a b Miller N (2005). Walsh and Hoyt's clinical neuro-ophthalmology (6 ed.). Philadelphia, Pa.: Lippincott Williams & Wilkins. p. 1275. ISBN 9780781748117. Archived from the original on 12 March 2017.
  154. ^ Liddell HG, Scott R. "ἡμικρανία". A Greek-English Lexicon. Archived from the original on 8 November 2013. on Perseus
  155. ^ Anderson K, Anderson LE, Glanze WD (1994). Mosby's Medical, Nursing & Allied Health Dictionary (4 ed.). Mosby. p. 998. ISBN 978-0-8151-6111-0.
  156. ^ a b c d e Borsook D (2012). The migraine brain : imaging, structure, and function. New York: Oxford University Press. pp. 3–11. ISBN 9780199754564. Archived from the original on 13 March 2017.
  157. ^ a b Waldman SD (2011). Pain management (2 ed.). Philadelphia, PA: Elsevier/Saunders. pp. 2122–2124. ISBN 9781437736038. Archived from the original on 23 August 2023. Retrieved 24 September 2016.
  158. ^ "Sex(ism), Drugs, and Migraines". Distillations. Science History Institute. 15 January 2019. Archived from the original on 14 March 2021. Retrieved 6 February 2020.
  159. ^ Margaret C, Simon M (2002). Human osteology: in archaeology and forensic science (Repr. ed.). Cambridge [etc.]: Cambridge University Press. p. 345. ISBN 9780521691468. Archived from the original on 17 June 2013.
  160. ^ Colen C (2008). Neurosurgery. Colen Publishing. p. 1. ISBN 9781935345039.
  161. ^ Daniel BT (2010). Migraine. Bloomington, IN: AuthorHouse. p. 101. ISBN 9781449069629. Archived from the original on 13 March 2017.
  162. ^ Butticè C (April 2022). What you need to know about headaches. Santa Barbara, California: Greenwood Publishing Group. pp. 29–30. ISBN 978-1-4408-7531-1. OCLC 1259297708. Archived from the original on 28 November 2022. Retrieved 2 November 2022.
  163. ^ a b Tfelt-Hansen PC, Koehler PJ (May 2011). "One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010". Headache. 51 (5): 752–78. doi:10.1111/j.1526-4610.2011.01892.x. PMID 21521208. S2CID 31940152.
  164. ^ Tfelt-Hansen P, Koehler P (2008). "History of the Use of Ergotamine and Dihydroergotamine in Migraine from 1906 and Onward". Cephalalgia. 28 (8): 877–886. doi:10.1111/j.1468-2982.2008.01578.x. PMID 18460007.
  165. ^ a b c Stovner LJ, Andrée C (June 2008). "Impact of headache in Europe: a review for the Eurolight project". The Journal of Headache and Pain. 9 (3): 139–46. doi:10.1007/s10194-008-0038-6. PMC 2386850. PMID 18418547.
  166. ^ a b Mennini FS, Gitto L, Martelletti P (August 2008). "Improving care through health economics analyses: cost of illness and headache". The Journal of Headache and Pain. 9 (4): 199–206. doi:10.1007/s10194-008-0051-9. PMC 3451939. PMID 18604472.
  167. ^ Magis D, Jensen R, Schoenen J (June 2012). "Neurostimulation therapies for primary headache disorders: present and future". Current Opinion in Neurology. 25 (3): 269–76. doi:10.1097/WCO.0b013e3283532023. PMID 22543428.
  168. ^ Jürgens TP, Leone M (June 2013). "Pearls and pitfalls: neurostimulation in headache". Cephalalgia. 33 (8): 512–25. doi:10.1177/0333102413483933. PMID 23671249. S2CID 42537455.
  169. ^ Barbanti P, Fofi L, Aurilia C, Egeo G, Caprio M (May 2017). "Ketogenic diet in migraine: rationale, findings and perspectives". Neurological Sciences (Review). 38 (Suppl 1): 111–115. doi:10.1007/s10072-017-2889-6. PMID 28527061. S2CID 3805337.
  170. ^ Gross EC, Klement RJ, Schoenen J, D'Agostino DP, Fischer D (April 2019). "Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention". Nutrients. 11 (4): 811. doi:10.3390/nu11040811. PMC 6520671. PMID 30974836.
  171. ^ Artero-Morales M, González-Rodríguez S, Ferrer-Montiel A (2018). "TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain". Frontiers in Molecular Biosciences. 5: 73. doi:10.3389/fmolb.2018.00073. PMC 6102492. PMID 30155469.
  172. ^ Stewart WF, Lipton RB, Celentano DD, Reed ML (January 1992). "Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors". JAMA. 267 (1): 64–69. doi:10.1001/jama.1992.03480010072027. PMID 1727198.
  173. ^ "Speeding Progress in Migraine Requires Unraveling Sex Differences". Society for Women's Health Research. 28 August 2018. Archived from the original on 18 June 2020. Retrieved 17 March 2021.

Further reading

[edit]
[edit]
The offline app allows you to download all of Wikipedia's medical articles in an app to access them when you have no Internet.
 
Wikipedia's health care articles can be viewed offline with the Medical Wikipedia app.
External audio
audio icon Sex(ism), Drugs, and Migraines, Distillations Podcast, Science History Institute, 15 January 2019

 

 

Headache
Other names Cephalalgia
Person with a headache
Specialty Neurology
Types Tension headache, cluster headache, sinusitis, migraine headache, hangover headache, cold-stimulus headache (brain freeze)
Treatment Over-the-counter painkillers, sleep, drinking water, eating food, head or neck massage

A headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck. It can occur as a migraine, tension-type headache, or cluster headache.[1][2] There is an increased risk of depression in those with severe headaches.[3]

Headaches can occur as a result of many conditions. There are a number of different classification systems for headaches. The most well-recognized is that of the International Headache Society, which classifies it into more than 150 types of primary and secondary headaches. Causes of headaches may include dehydration; fatigue; sleep deprivation; stress;[4] the effects of medications (overuse) and recreational drugs, including withdrawal; viral infections; loud noises; head injury; rapid ingestion of a very cold food or beverage; and dental or sinus issues (such as sinusitis).[5]

Treatment of a headache depends on the underlying cause, but commonly involves pain medication (especially in case of migraine or cluster headaches).[6] A headache is one of the most commonly experienced of all physical discomforts.[7]

About half of adults have a headache in a given year.[3] Tension headaches are the most common,[7] affecting about 1.6 billion people (21.8% of the population) followed by migraine headaches which affect about 848 million (11.7%).[8]

Causes

[edit]

There are more than 200 types of headaches. Some are harmless and some are life-threatening. The description of the headache and findings on neurological examination, determine whether additional tests are needed and what treatment is best.[9]

Headaches are broadly classified as "primary" or "secondary".[10] Primary headaches are benign, recurrent headaches not caused by underlying disease or structural problems. For example, migraine is a type of primary headache. While primary headaches may cause significant daily pain and disability, they are not dangerous from a physiological point of view. Secondary headaches are caused by an underlying disease, like an infection, head injury, vascular disorders, brain bleed, stomach irritation, or tumors. Secondary headaches can be dangerous. Certain "red flags" or warning signs indicate a secondary headache may be dangerous.[11]

Primary

[edit]

Ninety percent of all headaches are primary headaches.[12] Primary headaches usually first start when people are between 20 and 40 years old.[13][14] The most common types of primary headaches are migraines and tension-type headaches.[14] They have different characteristics. Migraines typically present with pulsing head pain, nausea, photophobia (sensitivity to light) and phonophobia (sensitivity to sound).[15] Tension-type headaches usually present with non-pulsing "bandlike" pressure on both sides of the head, not accompanied by other symptoms.[16][17] Such kind of headaches may be further classified into-episodic and chronic tension type headaches[18] Other very rare types of primary headaches include:[11]

  • cluster headaches: short episodes (15–180 minutes) of severe pain, usually around one eye, with autonomic symptoms (tearing, red eye, nasal congestion) which occur at the same time every day. Cluster headaches can be treated with triptans and prevented with prednisone, ergotamine or lithium.
  • trigeminal neuralgia or occipital neuralgia: shooting face pain
  • hemicrania continua: continuous unilateral pain with episodes of severe pain. Hemicrania continua can be relieved by the medication indomethacin.
  • primary stabbing headache: recurrent episodes of stabbing "ice pick pain" or "jabs and jolts" for 1 second to several minutes without autonomic symptoms (tearing, red eye, nasal congestion). These headaches can be treated with indomethacin.
  • primary cough headache: starts suddenly and lasts for several minutes after coughing, sneezing or straining (anything that may increase pressure in the head). Serious causes (see secondary headaches red flag section) must be ruled out before a diagnosis of "benign" primary cough headache can be made.
  • primary exertional headache: throbbing, pulsatile pain which starts during or after exercising, lasting for 5 minutes to 24 hours. The mechanism behind these headaches is unclear, possibly due to straining causing veins in the head to dilate, causing pain. These headaches can be prevented by not exercising too strenuously and can be treated with medications such as indomethacin.
  • primary sex headache: dull, bilateral headache that starts during sexual activity and becomes much worse during orgasm. These headaches are thought to be due to lower pressure in the head during sex. It is important to realize that headaches that begin during orgasm may be due to a subarachnoid hemorrhage, so serious causes must be ruled out first. These headaches are treated by advising the person to stop sex if they develop a headache. Medications such as propranolol and diltiazem can also be helpful.
  • hypnic headache: a moderate-severe headache that starts a few hours after falling asleep and lasts 15–30 minutes. The headache may recur several times during the night. Hypnic headaches are usually in older women. They may be treated with lithium.

Secondary

[edit]

Headaches may be caused by problems elsewhere in the head or neck. Some of these are not harmful, such as cervicogenic headache (pain arising from the neck muscles). The excessive use of painkillers can paradoxically cause worsening painkiller headaches.[9][19]

More serious causes of secondary headaches include the following:[11]

Gastrointestinal disorders may cause headaches, including Helicobacter pylori infection, celiac disease, non-celiac gluten sensitivity, irritable bowel syndrome, inflammatory bowel disease, gastroparesis, and hepatobiliary disorders.[20][21][22] The treatment of the gastrointestinal disorders may lead to a remission or improvement of headaches.[22]

Migraine headaches are also associated with Cyclic Vomiting Syndrome (CVS). CVS is characterized by episodes of severe vomiting, and often occur alongside symptoms similar to those of migraine headaches (photophobia, abdominal pain, etc.).[23]

Pathophysiology

[edit]

The brain itself is not sensitive to pain, because it lacks pain receptors. However, several areas of the head and neck do have pain receptors and can thus sense pain. These include the extracranial arteries, middle meningeal artery, large veins, venous sinuses, cranial and spinal nerves, head and neck muscles, the meninges, falx cerebri, parts of the brainstem, eyes, ears, teeth, and lining of the mouth.[24][25] Pial arteries, rather than pial veins are responsible for pain production.[11]

Headaches often result from traction or irritation of the meninges and blood vessels.[26] The pain receptors may be stimulated by head trauma or tumours and cause headaches. Blood vessel spasms, dilated blood vessels, inflammation or infection of meninges and muscular tension can also stimulate pain receptors.[25] Once stimulated, a nociceptor sends a message up the length of the nerve fibre to the nerve cells in the brain, signalling that a part of the body hurts.[27]

Primary headaches are more difficult to understand than secondary headaches. The exact mechanisms which cause migraines, tension headaches and cluster headaches are not known.[28] There have been different hypotheses over time that attempt to explain what happens in the brain to cause these headaches.[29]

Migraines are currently thought to be caused by dysfunction of the nerves in the brain.[30] Previously, migraines were thought to be caused by a primary problem with the blood vessels in the brain.[31] This vascular theory, which was developed in the 20th century by Wolff, suggested that the aura in migraines is caused by constriction of intracranial vessels (vessels inside the brain), and the headache itself is caused by rebound dilation of extracranial vessels (vessels just outside the brain). Dilation of these extracranial blood vessels activates the pain receptors in the surrounding nerves, causing a headache. The vascular theory is no longer accepted.[30][32] Studies have shown migraine head pain is not accompanied by extracranial vasodilation, but rather only has some mild intracranial vasodilation.[33]

Currently, most specialists think migraines are due to a primary problem with the nerves in the brain.[30] Auras are thought to be caused by a wave of increased activity of neurons in the cerebral cortex (a part of the brain) known as cortical spreading depression[34] followed by a period of depressed activity.[35] Some people think headaches are caused by the activation of sensory nerves which release peptides or serotonin, causing inflammation in arteries, dura and meninges and also cause some vasodilation. Triptans, medications that treat migraines, block serotonin receptors and constrict blood vessels.[36]

People who are more susceptible to experiencing migraines without headaches are those who have a family history of migraines, women, and women who are experiencing hormonal changes or are taking birth control pills or are prescribed hormone replacement therapy.[37]

Tension headaches are thought to be caused by the activation of peripheral nerves in the head and neck muscles.[38]

Cluster headaches involve overactivation of the trigeminal nerve and hypothalamus in the brain, but the exact cause is unknown.[28][39]

Diagnosis

[edit]
Differential diagnosis of headaches
Tension headache New daily persistent headache Cluster headache Migraine
mild to moderate dull or aching pain   severe pain moderate to severe pain
duration of 30 minutes to several hours duration of at least four hours daily duration of 30 minutes to 3 hours duration of 4 hours to 3 days
  Occur in periods of 15 days a month for three months may happen multiple times in a day for months periodic occurrence; several per month to several per year
located as tightness or pressure across head located on one or both sides of the head located one side of head focused at eye or temple located on one or both sides of head
  consistent pain pain describable as sharp or stabbing pulsating or throbbing pain
no nausea or vomiting     nausea, perhaps with vomiting
no aura no aura   auras
uncommonly, light sensitivity or noise sensitivity   may be accompanied by running nose, tears, and drooping eyelid, often only on one side sensitivity to movement, light, and noise
  exacerbated by regular use of acetaminophen or NSAIDS   may exist with tension headache[40]

Most headaches can be diagnosed by the clinical history alone.[11] If the symptoms described by the person sound dangerous, further testing with neuroimaging or lumbar puncture may be necessary. Electroencephalography (EEG) is not useful for headache diagnosis.[41]

The first step to diagnosing a headache is to determine if the headache is old or new.[42] A "new headache" can be a headache that has started recently, or a chronic headache that has changed character.[42] For example, if a person has chronic weekly headaches with pressure on both sides of his head, and then develops a sudden severe throbbing headache on one side of his head, they have a new headache.[citation needed]

Red flags

[edit]

It can be challenging to differentiate between low-risk, benign headaches and high-risk, dangerous headaches since symptoms are often similar.[43] Headaches that are possibly dangerous require further lab tests and imaging to diagnose.[14]

The American College for Emergency Physicians published criteria for low-risk headaches. They are as follows:[44]

  • age younger than 30 years
  • features typical of primary headache
  • history of similar headache
  • no abnormal findings on neurologic exam
  • no concerning change in normal headache pattern
  • no high-risk comorbid conditions (for example, HIV)
  • no new concerning history or physical examination findings

A number of characteristics make it more likely that the headache is due to potentially dangerous secondary causes which may be life-threatening or cause long-term damage. These "red flag" symptoms mean that a headache warrants further investigation with neuroimaging and lab tests.[14]

In general, people complaining of their "first" or "worst" headache warrant imaging and further workup.[14] People with progressively worsening headache also warrant imaging, as they may have a mass or a bleed that is gradually growing, pressing on surrounding structures and causing worsening pain.[43] People with neurological findings on exam, such as weakness, also need further workup.[43]

The American Headache Society recommends using "SSNOOP", a mnemonic to remember the red flags for identifying a secondary headache:[42]

  • Systemic symptoms (fever or weight loss)
  • Systemic disease (HIV infection, malignancy)
  • Neurologic symptoms or signs
  • Onset sudden (thunderclap headache)
  • Onset after age 40 years
  • Previous headache history (first, worst, or different headache)

Other red flag symptoms include:[14][42][43][45]

Red Flag Possible causes The reason why a red flag indicates possible causes Diagnostic tests
New headache after age 50 Temporal arteritis, mass in brain Temporal arteritis is an inflammation of vessels close to the temples in older people, which decreases blood flow to the brain and causes pain. May also have tenderness in temples or jaw claudication. Some brain cancers are more common in older people. Erythrocyte sedimentation rate (diagnostic test for temporal arteritis), neuroimaging
Very sudden onset headache (thunderclap headache) Brain bleed (subarachnoid hemorrhage, hemorrhage into mass lesion, vascular malformation), pituitary apoplexy, mass (especially in posterior fossa) A bleed in the brain irritates the meninges which causes pain. Pituitary apoplexy (bleeding or impaired blood supply to the pituitary gland at the base of the brain) is often accompanied by double vision or visual field defects, since the pituitary gland is right next to the optic chiasm (eye nerves). Neuroimaging, lumbar puncture if computed tomography is negative
Headaches increasing in frequency and severity Mass, subdural hematoma, medication overuse As a brain mass gets larger, or a subdural hematoma (blood outside the vessels underneath the dura) it pushes more on surrounding structures causing pain. Medication overuse headaches worsen with more medication taken over time. Neuroimaging, drug screen
New onset headache in a person with possible HIV or cancer Meningitis (chronic or carcinomatous), brain abscess including toxoplasmosis, metastasis People with HIV or cancer are immunosuppressed so are likely to get infections of the meninges or infections in the brain causing abscesses. Cancer can metastasize, or travel through the blood or lymph to other sites in the body. Neuroimaging, lumbar puncture if neuroimaging is negative
Headache with signs of total body illness (fever, stiff neck, rash) Meningitis, encephalitis (inflammation of the brain tissue), Lyme disease, collagen vascular disease A stiff neck, or inability to flex the neck due to pain, indicates inflammation of the meninges. Other signs of systemic illness indicates infection. Neuroimaging, lumbar puncture, serology (diagnostic blood tests for infections)
Papilledema Brain mass, benign intracranial hypertension (pseudotumor cerebri), meningitis Increased intracranial pressure pushes on the eyes (from inside the brain) and causes papilledema. Neuroimaging, lumbar puncture
Severe headache following head trauma Brain bleeds (intracranial hemorrhage, subdural hematoma, epidural hematoma), post-traumatic headache Trauma can cause bleeding in the brain or shake the nerves, causing a post-traumatic headache Neuroimaging of brain, skull, and possibly cervical spine
Inability to move a limb Arteriovenous malformation, collagen vascular disease, intracranial mass lesion Focal neurological signs indicate something is pushing against nerves in the brain responsible for one part of the body Neuroimaging, blood tests for collagen vascular diseases
Change in personality, consciousness, or mental status Central nervous system infection, intracranial bleed, mass Change in mental status indicates a global infection or inflammation of the brain, or a large bleed compressing the brainstem where the consciousness centers lie Blood tests, lumbar puncture, neuroimaging
Headache triggered by cough, exertion or while engaged in sexual intercourse Mass lesion, subarachnoid hemorrhage Coughing and exertion increases the intra cranial pressure, which may cause a vessel to burst, causing a subarachnoid hemorrhage. A mass lesion already increases intracranial pressure, so an additional increase in intracranial pressure from coughing etc. will cause pain. Neuroimaging, lumbar puncture

Old headaches

[edit]

Old headaches are usually primary headaches and are not dangerous. They are most often caused by migraines or tension headaches. Migraines are often unilateral, pulsing headaches accompanied by nausea or vomiting. There may be an aura (visual symptoms, numbness or tingling) 30–60 minutes before the headache, warning the person of a headache. Migraines may also not have auras.[45] Tension-type headaches usually have bilateral "bandlike" pressure on both sides of the head usually without nausea or vomiting. However, some symptoms from both headache groups may overlap. It is important to distinguish between the two because the treatments are different.[45]

The mnemonic 'POUND' helps distinguish between migraines and tension-type headaches. POUND stands for:

  • Pulsatile quality of headache
  • One-day duration (four to 72 hours)
  • Unilateral location
  • Nausea or vomiting
  • Disabling intensity[46]

One review article found that if 4–5 of the POUND characteristics are present, a migraine is 24 times as likely a diagnosis than a tension-type headache (likelihood ratio 24). If 3 characteristics of POUND are present, migraine is 3 times more likely a diagnosis than tension type headache (likelihood ratio 3).[17] If only 2 POUND characteristics are present, tension-type headaches are 60% more likely (likelihood ratio 0.41). Another study found the following factors independently each increase the chance of migraine over tension-type headache: nausea, photophobia, phonophobia, exacerbation by physical activity, unilateral, throbbing quality, chocolate as a headache trigger, and cheese as a headache trigger.[47]

Cluster headaches are relatively rare (1 in 1000 people) and are more common in men than women.[48] They present with sudden onset explosive pain around one eye and are accompanied by autonomic symptoms (tearing, runny nose and red eye).[11]

Temporomandibular jaw pain (chronic pain in the jaw joint), and cervicogenic headache (headache caused by pain in muscles of the neck) are also possible diagnoses.[42]

For chronic, unexplained headaches, keeping a headache diary can be useful for tracking symptoms and identifying triggers, such as association with menstrual cycle, exercise and food. While mobile electronic diaries for smartphones are becoming increasingly common, a recent review found most are developed with a lack of evidence base and scientific expertise.[49]

Cephalalgiaphobia is fear of headaches or getting a headache.

New headaches

[edit]

New headaches are more likely to be dangerous secondary headaches. They can, however, simply be the first presentation of a chronic headache syndrome, like migraine or a tension headache.

One recommended diagnostic approach is as follows.[50] If any urgent red flags are present such as visual impairment, new seizures, new weakness, or new confusion, further workup with imaging and possibly a lumbar puncture should be done (see red flags section for more details). If the headache is sudden onset (thunderclap headache), a computed tomography scan (CT scan) to look for a brain bleed (subarachnoid hemorrhage) should be done. If the CT scan does not show a bleed, a lumbar puncture should be done to look for blood in the cerebrospinal fluid (CSF), as the CT scan can be falsely negative and subarachnoid hemorrhages can be fatal. If there are signs of infection such as fever, rash, or stiff neck, a lumbar puncture to look for meningitis should be considered. In an older person, if there is jaw claudication and scalp tenderness, a temporal artery biopsy should be performed to look for temporal arteritis, immediate treatment should be started, if results of the biopsy are positive.[citation needed]

Neuroimaging

[edit]

Old headaches

[edit]

The US Headache Consortium has guidelines for neuroimaging of non-acute headaches.[51] Most old, chronic headaches do not require neuroimaging. If a person has the characteristic symptoms of a migraine, neuroimaging is not needed as it is very unlikely the person has an intracranial abnormality.[52] If the person has neurological findings, such as weakness, on exam, neuroimaging may be considered.[citation needed]

New headaches

[edit]

All people who present with red flags indicating a dangerous secondary headache should receive neuroimaging.[45] The best form of neuroimaging for these headaches is controversial.[14] Non-contrast computerized tomography (CT) scan is usually the first step in head imaging as it is readily available in Emergency Departments and hospitals and is cheaper than MRI. Non-contrast CT is best for identifying an acute head bleed. Magnetic Resonance Imaging (MRI) is best for brain tumors and problems in the posterior fossa, or back of the brain.[14] MRI is more sensitive for identifying intracranial problems, however it can pick up brain abnormalities that are not relevant to the person's headaches.[14]

The American College of Radiology recommends the following imaging tests for different specific situations:[53]

Clinical Features Recommended neuroimaging test
Headache in immunocompromised people (cancer, HIV) MRI of head with or without contrast
Headache in people older than 60 with suspected temporal arteritis MRI of head with or without contrast
Headache with suspected meningitis CT or MRI without contrast
Severe headache in pregnancy CT or MRI without contrast
Severe unilateral headache caused by possible dissection of carotid or arterial arteries MRI of head with or without contrast, magnetic resonance angiography or Computed Tomography Angiography of head and neck.
Sudden onset headache or worst headache of life CT of head without contrast, Computed Tomography Angiography of head and neck with contrast, magnetic resonance angiography of head and neck with and without contrast, MRI of head without contrast

Lumbar puncture

[edit]

A lumbar puncture is a procedure in which cerebral spinal fluid is removed from the spine with a needle. A lumbar puncture is necessary to look for infection or blood in the spinal fluid. A lumbar puncture can also evaluate the pressure in the spinal column, which can be useful for people with idiopathic intracranial hypertension (usually young, obese women who have increased intracranial pressure), or other causes of increased intracranial pressure. In most cases, a CT scan should be done first.[11]

Classification

[edit]

Headaches are most thoroughly classified by the International Headache Society's International Classification of Headache Disorders (ICHD), which published the second edition in 2004.[54] The third edition of the International Headache Classification was published in 2013 in a beta version ahead of the final version.[55] This classification is accepted by the WHO.[56]

Other classification systems exist. One of the first published attempts was in 1951.[57] The US National Institutes of Health developed a classification system in 1962.[58]

ICHD-2

[edit]

The International Classification of Headache Disorders (ICHD) is an in-depth hierarchical classification of headaches published by the International Headache Society. It contains explicit (operational) diagnostic criteria for headache disorders. The first version of the classification, ICHD-1, was published in 1988. The current revision, ICHD-2, was published in 2004.[59] The classification uses numeric codes. The top, one-digit diagnostic level includes 14 headache groups. The first four of these are classified as primary headaches, groups 5-12 as secondary headaches, cranial neuralgia, central and primary facial pain and other headaches for the last two groups.[60]

The ICHD-2 classification defines migraines, tension-types headaches, cluster headache and other trigeminal autonomic headache as the main types of primary headaches.[54] Also, according to the same classification, stabbing headaches and headaches due to cough, exertion and sexual activity (sexual headache) are classified as primary headaches. The daily-persistent headaches along with the hypnic headache and thunderclap headaches are considered primary headaches as well.[61][62]

Secondary headaches are classified based on their cause and not on their symptoms.[54] According to the ICHD-2 classification, the main types of secondary headaches include those that are due to head or neck trauma such as whiplash injury, intracranial hematoma, post craniotomy or other head or neck injury. Headaches caused by cranial or cervical vascular disorders such as ischemic stroke and transient ischemic attack, non-traumatic intracranial hemorrhage, vascular malformations or arteritis are also defined as secondary headaches. This type of headache may also be caused by cerebral venous thrombosis or different intracranial vascular disorders. Other secondary headaches are those due to intracranial disorders that are not vascular such as low or high pressure of the cerebrospinal fluid pressure, non-infectious inflammatory disease, intracranial neoplasm, epileptic seizure or other types of disorders or diseases that are intracranial but that are not associated with the vasculature of the central nervous system.[citation needed]

ICHD-2 classifies headaches that are caused by the ingestion of a certain substance or by its withdrawal as secondary headaches as well. This type of headache may result from the overuse of some medications or exposure to some substances. HIV/AIDS, intracranial infections and systemic infections may also cause secondary headaches. The ICHD-2 system of classification includes the headaches associated with homeostasis disorders in the category of secondary headaches. This means that headaches caused by dialysis, high blood pressure, hypothyroidism, cephalalgia and even fasting are considered secondary headaches. Secondary headaches, according to the same classification system, can also be due to the injury of any of the facial structures including teeth, jaws, or temporomandibular joint. Headaches caused by psychiatric disorders such as somatization or psychotic disorders are also classified as secondary headaches.[citation needed]

The ICHD-2 classification puts cranial neuralgias and other types of neuralgia in a different category. According to this system, there are 19 types of neuralgias and headaches due to different central causes of facial pain. Moreover, the ICHD-2 includes a category that contains all the headaches that cannot be classified.[citation needed]

Although the ICHD-2 is the most complete headache classification there is and it includes frequency in the diagnostic criteria of some types of headaches (primarily primary headaches), it does not specifically code frequency or severity which are left at the discretion of the examiner.[54]

NIH

[edit]

The NIH classification consists of brief definitions of a limited number of headaches.[63]

The NIH system of classification is more succinct and only describes five categories of headaches. In this case, primary headaches are those that do not show organic or structural causes. According to this classification, primary headaches can only be vascular, myogenic, cervicogenic, traction, and inflammatory.[64]

Management

[edit]
An old advertisement for a headache medicine

Primary headache syndromes have many different possible treatments. In those with chronic headaches the long term use of opioids appears to result in greater harm than benefit.[65]

Secondary headaches (caused by another disease)

[edit]

Treatment of secondary headaches involves treating their underlying cause. For example, a person with meningitis will require antibiotics, and a person with a brain tumor may require surgery, chemotherapy or brain radiation. The possible origins of a headache have been studied and classified.

Migraines

[edit]

Migraine can be somewhat improved by lifestyle changes, but most people require medicines to control their symptoms.[11] Medications are either to prevent getting migraines, or to reduce symptoms once a migraine starts.[citation needed]

Preventive medications are generally recommended when people have more than four attacks of migraine per month, headaches last longer than 12 hours or the headaches are very disabling.[11][66] Possible therapies include beta blockers, antidepressants, anticonvulsants and NSAIDs.[66] The type of preventive medicine is usually chosen based on the other symptoms the person has. For example, if the person also has depression, an antidepressant is a good choice.[citation needed]

Abortive therapies for migraines may be oral, if the migraine is mild to moderate, or may require stronger medicine given intravenously or intramuscularly. Mild to moderate headaches should first be treated with acetaminophen (paracetamol) or NSAIDs, like ibuprofen. If accompanied by nausea or vomiting, an antiemetic such as metoclopramide (Reglan) can be given orally or rectally. Moderate to severe attacks should be treated first with an oral triptan, a medication that mimics serotonin (an agonist) and causes mild vasoconstriction. If accompanied by nausea and vomiting, parenteral (through a needle in the skin) triptans and antiemetics can be given.[67]

Sphenopalatine ganglion block (SPG block, also known nasal ganglion block or pterygopalatine ganglion blocks) can abort and prevent migraines, tension headaches and cluster headaches. It was originally described by American ENT surgeon Greenfield Sluder in 1908. Both blocks and neurostimulation have been studied as treatment for headaches.[68]

Several complementary and alternative strategies can help with migraines. The American Academy of Neurology guidelines for migraine treatment in 2000 stated relaxation training, electromyographic feedback and cognitive behavioral therapy may be considered for migraine treatment, along with medications.[69]

Tension-type headaches

[edit]

Tension-type headaches can usually be managed with NSAIDs (ibuprofen, naproxen, aspirin), or acetaminophen.[11] Triptans are not helpful in tension-type headaches unless the person also has migraines. For chronic tension type headaches, amitriptyline is the only medication proven to help.[11][70][71] Amitriptyline is a medication which treats depression and also independently treats pain. It works by blocking the reuptake of serotonin and norepinephrine, and also reduces muscle tenderness by a separate mechanism.[70] Studies evaluating acupuncture for tension-type headaches have been mixed.[72][73][74][75][76] Overall, they show that acupuncture is probably not helpful for tension-type headaches.

Cluster headaches

[edit]

Abortive therapy for cluster headaches includes subcutaneous sumatriptan (injected under the skin) and triptan nasal sprays. High flow oxygen therapy also helps with relief.[11]

For people with extended periods of cluster headaches, preventive therapy can be necessary. Verapamil is recommended as first line treatment. Lithium can also be useful. For people with shorter bouts, a short course of prednisone (10 days) can be helpful. Ergotamine is useful if given 1–2 hours before an attack.[11]

Neuromodulation

[edit]

Peripheral neuromodulation has tentative benefits in primary headaches including cluster headaches and chronic migraine.[77] How it may work is still being looked into.[77]

Epidemiology

[edit]

Literature reviews find that approximately 64–77% of adults have had a headache at some point in their lives.[78][79] During each year, on average, 46–53% of people have headaches.[78][79] However, the prevalence of headache varies widely depending on how the survey was conducted, with studies finding lifetime prevalence of as low as 8% to as high as 96%.[78][79][80] Most of these headaches are not dangerous. Only approximately 1–5% of people who seek emergency treatment for headaches have a serious underlying cause.[81]

More than 90% of headaches are primary headaches.[82] Most of these primary headaches are tension headaches.[79] Most people with tension headaches have "episodic" tension headaches that come and go. Only 3.3% of adults have chronic tension headaches, with headaches for more than 15 days in a month.[79]

Approximately 12–18% of people in the world have migraines.[79] More women than men experience migraines. In Europe and North America, 5–9% of men experience migraines, while 12–25% of women experience migraines.[78]

Cluster headaches are relatively uncommon. They affect only 1–3 per thousand people in the world. Cluster headaches affect approximately three times as many men as women.[79]

History

[edit]
An 1819 caricature by George Cruikshank depicting a headache

The first recorded classification system was published by Aretaeus of Cappadocia, a medical scholar of Greco-Roman antiquity. He made a distinction between three different types of headache: i) cephalalgia, by which he indicates a sudden onset, temporary headache; ii) cephalea, referring to a chronic type of headache; and iii) heterocrania, a paroxysmal headache on one side of the head. Another classification system that resembles the modern ones was published by Thomas Willis, in De Cephalalgia in 1672. In 1787 Christian Baur generally divided headaches into idiopathic (primary headaches) and symptomatic (secondary ones), and defined 84 categories.[63]

Children

[edit]

In general, children experience the same types of headaches as adults do, but their symptoms may be slightly different. The diagnostic approach to headaches in children is similar to that of adults. However, young children may not be able to verbalize pain well.[83] If a young child is fussy, they may have a headache.[84]

Approximately 1% of emergency department visits for children are for headache.[85][86] Most of these headaches are not dangerous. The most common type of headache seen in pediatric emergency rooms is headache caused by a cold (28.5%). Other headaches diagnosed in the emergency department include post-traumatic headache (20%), headache related to a problem with a ventriculoperitoneal shunt (a device put into the brain to remove excess CSF and reduce pressure in the brain) (11.5%) and migraine (8.5%).[86][87] The most common serious headaches found in children include brain bleeds (subdural hematoma, epidural hematoma), brain abscesses, meningitis and ventriculoperitoneal shunt malfunction. Only 4–6.9% of kids with a headache have a serious cause.[84]

Just as in adults, most headaches are benign, but when head pain is accompanied with other symptoms such as speech problems, muscle weakness, and loss of vision, a more serious underlying cause may exist: hydrocephalus, meningitis, encephalitis, abscess, hemorrhage, tumor, blood clots, or head trauma. In these cases, the headache evaluation may include CT scan or MRI in order to look for possible structural disorders of the central nervous system.[88] If a child with a recurrent headache has a normal physical exam, neuroimaging is not recommended. Guidelines state children with abnormal neurologic exams, confusion, seizures and recent onset of worst headache of life, change in headache type or anything suggesting neurologic problems should receive neuroimaging.[84]

When children complain of headaches, many parents are concerned about a brain tumor. Generally, headaches caused by brain masses are incapacitating and accompanied by vomiting.[84] One study found characteristics associated with brain tumor in children are: headache for greater than 6 months, headache related to sleep, vomiting, confusion, no visual symptoms, no family history of migraine and abnormal neurologic exam.[89]

Some measures can help prevent headaches in children. Drinking plenty of water throughout the day, avoiding caffeine, getting enough and regular sleep, eating balanced meals at the proper times, and reducing stress and excess of activities may prevent headaches.[90] Treatments for children are similar to those for adults, however certain medications such as narcotics should not be given to children.[84]

Children who have headaches will not necessarily have headaches as adults. In one study of 100 children with headache, eight years later 44% of those with tension headache and 28% of those with migraines were headache free.[91] In another study of people with chronic daily headache, 75% did not have chronic daily headaches two years later, and 88% did not have chronic daily headaches eight years later.[92]

Cardiac Cephalgia in Heart Attack

[edit]

Cardiac cephalgia[93] is a rare type of headache occurring during myocardial infarction, characterized by sudden, severe head pain that typically develops during or immediately following a heart attack. The pain is usually located in the occipital or frontal regions and can be accompanied by other cardiac symptoms like chest pain, shortness of breath, or radiating arm pain. This specific headache type is considered a potential warning sign of cardiac distress and requires immediate medical attention to prevent potentially life-threatening complications.[94]

See also

[edit]

References

[edit]
  1. ^ "Headache disorders". The World Health Organization. 8 April 2016. Retrieved 2021-12-14.
  2. ^ Silberstein SD (2022-03-09), Lynch ME, Craig KD, Peng PW (eds.), "Headache", Clinical Pain Management (1 ed.), Wiley, pp. 336–342, doi:10.1002/9781119701170.ch32, ISBN 978-1-119-70115-6, retrieved 2022-04-29
  3. ^ a b "Headache disorders Fact sheet N° 277". The World Health Organization. 8 April 2016. Archived from the original on 16 February 2016. Retrieved 15 February 2016.
  4. ^ Britton CB (2013), Green MW, Muskin PR (eds.), "Stress and headache", The Neuropsychiatry of Headache, Cambridge: Cambridge University Press, pp. 54–62, doi:10.1017/cbo9781139206952.007, ISBN 978-1-107-02620-9, retrieved 2022-04-29
  5. ^ "Headache Causes". Mayo Clinic. Retrieved 21 October 2019.
  6. ^ "Headache". Johns Hopkins Medicine. The Johns Hopkins University. Retrieved 2021-12-14.
  7. ^ a b Ahmed F (August 2012). "Headache disorders: differentiating and managing the common subtypes". British Journal of Pain. 6 (3): 124–132. doi:10.1177/2049463712459691. PMC 4590146. PMID 26516483.
  8. ^ Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (Global Burden of Disease Study 2013 Collaborators) (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
  9. ^ a b Scottish Intercollegiate Network (November 2008). Diagnosis and management of headache in adults. Edinburgh: NHS Quality Improvement Scotland. ISBN 978-1-905813-39-1. Archived from the original on 19 April 2011. Retrieved 14 July 2010.
  10. ^ Young CB (3 January 2012). "The Johns Hopkins Headache Center - Primary Exertion Headache". hopkinsmedicine.org. Archived from the original on 3 May 2014.
  11. ^ a b c d e f g h i j k l m Goadsby PJ, Raskin NH (2012). "Chapter 14. Headache". In Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J (eds.). Harrison's Principles of Internal Medicine (18th ed.). New York, NY: McGraw-Hill. ISBN 978-0-07-174890-2.
  12. ^ Damayanti Y, Marhaendraputro EA, Santoso WM, Rahmawati D (2021-03-02). "Profile of Primary Patients in Neurological Polyclinic". Journal of Pain, Headache and Vertigo. 2 (1): 1–4. doi:10.21776/ub.jphv.2021.002.01.1. ISSN 2723-3960. S2CID 233777394.
  13. ^ Straube A, Andreou A (April 2019). "Primary headaches during lifespan". The Journal of Headache and Pain. 20 (1): 35. doi:10.1186/s10194-019-0985-0. PMC 6734460. PMID 30961531.
  14. ^ a b c d e f g h i South-Paul JE, Matheny SC, Lewis EL (2011). Clinch C. Chapter 28. Evaluation & Management of Headache - CURRENT Diagnosis & Treatment in Family Medicine. Lange Current Series (Third ed.). McGraw-Hill. ISBN 978-0-07-162436-7.
  15. ^ "Migraine - Symptoms and causes". Mayo Clinic. Retrieved 2021-12-15.
  16. ^ "Tension Headaches". www.hopkinsmedicine.org. 8 August 2021. Retrieved 2021-12-15.
  17. ^ a b Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM (September 2006). "Does this patient with headache have a migraine or need neuroimaging?". JAMA. 296 (10): 1274–1283. doi:10.1001/jama.296.10.1274. PMID 16968852.
  18. ^ "Tension headache - Symptoms and causes". Mayo Clinic. Retrieved 2021-12-15.
  19. ^ "Headaches". nhs.uk. 8 January 2018.
  20. ^ Lionetti E, Francavilla R, Pavone P, Pavone L, Francavilla T, Pulvirenti A, et al. (August 2010). "The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis". Developmental Medicine and Child Neurology (Systematic review and meta-analysis). 52 (8): 700–707. doi:10.1111/j.1469-8749.2010.03647.x. PMID 20345955. S2CID 205611320.Open access icon
  21. ^ Aziz I, Hadjivassiliou M, Sanders DS (September 2015). "The spectrum of noncoeliac gluten sensitivity". Nature Reviews. Gastroenterology & Hepatology (Review). 12 (9): 516–526. doi:10.1038/nrgastro.2015.107. PMID 26122473. S2CID 2867448.
  22. ^ a b Cámara-Lemarroy CR, Rodriguez-Gutierrez R, Monreal-Robles R, Marfil-Rivera A (September 2016). "Gastrointestinal disorders associated with migraine: A comprehensive review". World Journal of Gastroenterology (Review). 22 (36): 8149–8160. doi:10.3748/wjg.v22.i36.8149. PMC 5037083. PMID 27688656.
  23. ^ Hasler WL, Levinthal DJ, Tarbell SE, Adams KA, Li BU, Issenman RM, et al. (June 2019). "Cyclic vomiting syndrome: Pathophysiology, comorbidities, and future research directions". Neurogastroenterology and Motility. 31 (Suppl 2): e13607. doi:10.1111/nmo.13607. PMC 6899706. PMID 31241816.
  24. ^ Edlow JA, Panagos PD, Godwin SA, Thomas TL, Decker WW (October 2008). "Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache". Annals of Emergency Medicine. 52 (4): 407–436. doi:10.1016/j.annemergmed.2008.07.001. PMID 18809105. S2CID 507361.
  25. ^ a b Greenberg D, Aminoff M, Simon R (6 May 2012). Clinical Neurology 8/E:Chapter 6. Headache & Facial Pain. McGraw Hill Professional. ISBN 978-0-07-175905-2.
  26. ^ "headache | Britannica". www.britannica.com. Retrieved 2022-04-29.
  27. ^ Dubin AE, Patapoutian A (November 2010). "Nociceptors: the sensors of the pain pathway". The Journal of Clinical Investigation. 120 (11): 3760–3772. doi:10.1172/JCI42843. PMC 2964977. PMID 21041958.
  28. ^ a b Leroux E, Ducros A (July 2008). "Cluster headache". Orphanet Journal of Rare Diseases. 3 (1): 20. doi:10.1186/1750-1172-3-20. PMC 2517059. PMID 18651939.
  29. ^ "How a Migraine Happens". www.hopkinsmedicine.org. 26 November 2019. Retrieved 2021-12-18.
  30. ^ a b c Cutrer FM, Bajwa A, Sabhat M. Post TW (ed.). "Pathophysiology, clinical manifestations and diagnosis of migraine in adults". UpToDate. San Francisco, CA: Wolters Kluwer. Retrieved 23 April 2014.
  31. ^ Goadsby PJ (January 2009). "The vascular theory of migraine--a great story wrecked by the facts". Brain. 132 (Pt 1): 6–7. doi:10.1093/brain/awn321. PMID 19098031.
  32. ^ Charles A (May 2013). "Vasodilation out of the picture as a cause of migraine headache". The Lancet. Neurology. 12 (5): 419–420. doi:10.1016/s1474-4422(13)70051-6. PMID 23578774. S2CID 42240966.
  33. ^ Amin FM, Asghar MS, Hougaard A, Hansen AE, Larsen VA, de Koning PJ, et al. (May 2013). "Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study". The Lancet. Neurology. 12 (5): 454–461. doi:10.1016/S1474-4422(13)70067-X. PMID 23578775. S2CID 25553357.
  34. ^ Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, et al. (April 2001). "Mechanisms of migraine aura revealed by functional MRI in human visual cortex". Proceedings of the National Academy of Sciences of the United States of America. 98 (8): 4687–4692. Bibcode:2001PNAS...98.4687H. doi:10.1073/pnas.071582498. PMC 31895. PMID 11287655.
  35. ^ Buzzi MG, Moskowitz MA (June 2005). "The pathophysiology of migraine: year 2005". The Journal of Headache and Pain. 6 (3): 105–111. doi:10.1007/s10194-005-0165-2. PMC 3451639. PMID 16355290.
  36. ^ Denny CJ, Schull MJ (2011). "Chapter 159. Headache and Facial Pain.". In Tintinalli JE, Stapczynski J, Ma O, Cline DM, Cydulka RK, Meckler GD (eds.). Tintinalli's Emergency Medicine: A Comprehensive Study Guide (7th ed.). New York, NY: The McGraw-Hill Companies. Archived from the original on 31 May 2015. Retrieved 30 May 2015.
  37. ^ "Migraine Without Headache". Neurobalance. Archived from the original on 8 January 2015. Retrieved 16 July 2014.
  38. ^ Loder E, Rizzoli P (January 2008). "Tension-type headache". BMJ. 336 (7635): 88–92. doi:10.1136/bmj.39412.705868.ad. PMC 2190284. PMID 18187725.
  39. ^ Levin EL (2019). "Cluster Headache". Pain Neurosurgery. Oxford University Press. pp. 125–130. doi:10.1093/med/9780190887674.003.0016. ISBN 978-0-19-088770-4.
  40. ^ "Using the triptans to treat: Migraine headaches: Comparing effectiveness, safety, and price" (PDF). Consumer Reports Best Buy Drugs: 8. March 2013. Archived (PDF) from the original on 20 March 2013. Retrieved 18 March 2013.
  41. ^ Gronseth GS, Greenberg MK (July 1995). "The utility of the electroencephalogram in the evaluation of patients presenting with headache: a review of the literature". Neurology. 45 (7): 1263–1267. doi:10.1212/WNL.45.7.1263. PMID 7617180. S2CID 26022438.
  42. ^ a b c d e Smetana GW (2012). "Chapter 9. Headache.". In Henderson MC, Tierney Jr LM, Smetana GW (eds.). The Patient History: An Evidence-Based Approach to Differential Diagnosis. New York, NY: McGraw-Hill. Archived from the original on 31 May 2015.
  43. ^ a b c d Abrams BM (March 2013). "Factors that cause concern". The Medical Clinics of North America. 97 (2): 225–242. doi:10.1016/j.mcna.2012.11.002. PMID 23419623.
  44. ^ American College of Emergency Physicians (January 2002). "Clinical policy: critical issues in the evaluation and management of patients presenting to the emergency department with acute headache". Annals of Emergency Medicine. 39 (1): 108–122. doi:10.1067/mem.2002.120125. PMID 11782746.
  45. ^ a b c d Hainer BL, Matheson EM (May 2013). "Approach to acute headache in adults". American Family Physician. 87 (10): 682–687. PMID 23939446.
  46. ^ Gilmore B, Michael M (February 2011). "Treatment of acute migraine headache". American Family Physician. 83 (3): 271–280. PMID 21302868. Retrieved 15 September 2021.
  47. ^ Smetana GW (October 2000). "The diagnostic value of historical features in primary headache syndromes: a comprehensive review". Archives of Internal Medicine. 160 (18): 2729–2737. doi:10.1001/archinte.160.18.2729. PMID 11025782.
  48. ^ Harrison's Principles of Internal Medicine (19th ed.). McGraw-Hill Education. 8 April 2015. pp. 2594–2595. ISBN 978-0-07-180215-4.
  49. ^ Hundert AS, Huguet A, McGrath PJ, Stinson JN, Wheaton M (August 2014). "Commercially available mobile phone headache diary apps: a systematic review". JMIR mHealth and uHealth. 2 (3): e36. doi:10.2196/mhealth.3452. PMC 4147710. PMID 25138438.
  50. ^ Stern SC, Cifu AS, Altkorn D, eds. (2010). "Chapter 18: I Have a Patient with Headache. How Do I Determine the Cause?". Symptom to Diagnosis: An Evidence-Based Guide (2nd ed.). New York, NY: McGraw-Hill. Archived from the original on 31 May 2015.
  51. ^ Frishberg BM, Rosenberg JH, Matchar DB, McCrory DC, Pietrzak MP, Rozen TD, et al. (April 2000). Evidence-based guidelines in the primary care setting: neuroimaging in patients with nonacute headache. St Paul, MN: US Headache Consortium. pp. 1–25. CiteSeerX 10.1.1.565.1524.
  52. ^ American Headache Society (September 2013). "Five Things Physicians and Patients Should Question". Choosing Wisely. American Headache Society. Archived from the original on 6 December 2013. Retrieved 10 December 2013., which cites
  53. ^ Strain JD, Strife JL, Kushner DC, Babcock DS, Cohen HL, Gelfand MJ, et al. (June 2000). "Headache. American College of Radiology. ACR Appropriateness Criteria". Radiology. 215 (Suppl): 855–60. PMID 11037510.
  54. ^ a b c d IHS Classification ICHD-2 (Online ed.). International Headache Society. Archived from the original on 3 November 2013. Retrieved 18 November 2013.
  55. ^ Website The International Headache Classification (ICHD-3 Beta). Retrieved 29. August 2016.
  56. ^ Olesen et al. 2005, pp. 9–11.
  57. ^ Brown MR (September 1951). "The classification and treatment of headache". The Medical Clinics of North America. 35 (5): 1485–1493. doi:10.1016/S0025-7125(16)35236-1. PMID 14862569.
  58. ^ Ad Hoc Committee on Classification of Headache (1962). "Classification of Headache". JAMA. 179 (9): 717–8. doi:10.1001/jama.1962.03050090045008.
  59. ^ Olesen PJ, Goadsby NM, Ramadan P, Tfelt-Hansen KM, Welch (2005). The Headaches (3 ed.). Lippincott Williams & Wilkins.
  60. ^ Levin M, Baskin SM, Bigal ME (2008). Comprehensive Review of Headache Medicine. Oxford University Press. ISBN 978-0-19-536673-0.
  61. ^ Linn FH (2010). "Primary thunderclap headache". Headache. Handbook of Clinical Neurology. Vol. 97. Elsevier. pp. 473–481. doi:10.1016/s0072-9752(10)97042-5. ISBN 978-0-444-52139-2. PMID 20816448.
  62. ^ Obermann M, Holle D (September 2010). "Hypnic headache". Expert Review of Neurotherapeutics. 10 (9): 1391–1397. doi:10.1586/ern.10.112. PMID 20839413. S2CID 19141493.
  63. ^ a b Levin et al. 2008, p. 60.
  64. ^ "Headache Information Page | National Institute of Neurological Disorders and Stroke". www.ninds.nih.gov. Retrieved 21 July 2021.
  65. ^ Franklin GM (September 2014). "Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology". Neurology. 83 (14): 1277–1284. doi:10.1212/WNL.0000000000000839. PMID 25267983.
  66. ^ a b Bajwa ZH, Sabahat A. Swanson JW (ed.). Preventive Treatment of Migraine in Adults. UptoDate (Report). San Francisco, CA.: Wolters Kluwer.
  67. ^ Láinez MJ, García-Casado A, Gascón F (October 2013). "Optimal management of severe nausea and vomiting in migraine: improving patient outcomes". Patient Related Outcome Measures. 4: 61–73. doi:10.2147/PROM.S31392. PMC 3798203. PMID 24143125.
  68. ^ Boss KW, Przkora R, Kumar S (December 2017). "Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review". The Journal of Headache and Pain. 18 (1): 118. doi:10.1186/s10194-017-0826-y. PMC 5745368. PMID 29285576.
  69. ^ Silberstein SD (September 2000). "Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 55 (6): 754–762. doi:10.1212/wnl.55.6.754. PMID 10993991.
  70. ^ a b Taylor R. Swanson JW (ed.). "Tension type headaches in adults: Preventive treatment". UpToDate. San Francisco, CA: Wolters Kluwer. Retrieved 24 April 2014.
  71. ^ Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M, et al. (October 2010). "Tricyclic antidepressants and headaches: systematic review and meta-analysis". BMJ. 341: c5222. doi:10.1136/bmj.c5222. PMC 2958257. PMID 20961988.
  72. ^ Davis MA, Kononowech RW, Rolin SA, Spierings EL (August 2008). "Acupuncture for tension-type headache: a meta-analysis of randomized, controlled trials". The Journal of Pain. 9 (8): 667–677. doi:10.1016/j.jpain.2008.03.011. PMID 18499526.
  73. ^ Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Shin BC, et al. (April 2016). "Acupuncture for the prevention of tension-type headache". The Cochrane Database of Systematic Reviews. 4 (8): CD007587. doi:10.1002/14651858.CD007587.pub2. PMC 4955729. PMID 27092807.
  74. ^ Hao XA, Xue CC, Dong L, Zheng Z (April 2013). "Factors associated with conflicting findings on acupuncture for tension-type headache: qualitative and quantitative analyses". Journal of Alternative and Complementary Medicine. 19 (4): 285–297. doi:10.1089/act.2013.19608. PMID 23075410.
  75. ^ Melchart D, Streng A, Hoppe A, Brinkhaus B, Becker-Witt C, Hammes M, et al. (December 2005). "The acupuncture randomised trial (ART) for tension-type headache--details of the treatment". Acupuncture in Medicine. 23 (4): 157–165. doi:10.1136/aim.23.4.157. PMID 16430123. S2CID 23437975.
  76. ^ Melchart D, Streng A, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, et al. (August 2005). "Acupuncture in patients with tension-type headache: randomised controlled trial". BMJ. 331 (7513): 376–382. doi:10.1136/bmj.38512.405440.8f. PMC 1184247. PMID 16055451.
  77. ^ a b Reed KL (January 2013). "Peripheral neuromodulation and headaches: history, clinical approach, and considerations on underlying mechanisms". Current Pain and Headache Reports. 17 (1): 305. doi:10.1007/s11916-012-0305-8. PMC 3548086. PMID 23274677.
  78. ^ a b c d Manzoni GC, Stovner LJ (2010). "Epidemiology of headache". Headache. Handbook of Clinical Neurology. Vol. 97. pp. 3–22. doi:10.1016/s0072-9752(10)97001-2. ISBN 978-0-444-52139-2. PMID 20816407. [T]he prevalence [of headache within the last year] was on average 46% based on 35 different studies from all over the world, but the variation was immense, between 1% and 87%. The lifetime prevalence was much as expected – 64%, varying between 8% and 96% in 14 studies. For current chronic headache, the average of 10 studies was 3.4%, varying between 1.7% and 7.3%.
  79. ^ a b c d e f g Stovner LJ, Andree C (August 2010). "Prevalence of headache in Europe: a review for the Eurolight project". The Journal of Headache and Pain. 11 (4): 289–299. doi:10.1007/s10194-010-0217-0. PMC 2917556. PMID 20473702. Calculating the mean of all the studies comprising more than 205,000 adult participants, current headache [i.e. headache within the last year] occurred in 53% of adults (61% among women and 45% among men).... The total lifetime prevalence of headache among adults was as expected higher than that of current headache (77%).
  80. ^ Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. (March 2007). "The global burden of headache: a documentation of headache prevalence and disability worldwide". Cephalalgia. 27 (3): 193–210. doi:10.1111/j.1468-2982.2007.01288.x. PMID 17381554. S2CID 23927368.
  81. ^ Mattu M, Goyal D, Barrett JW, Broder J, DeAngelis M, Deblieux P, et al. (2007). Emergency medicine: Avoiding the pitfalls and improving the outcomes. Malden, MA: Blackwell / BMJ Books. p. 39. ISBN 978-1-4051-4166-6.
  82. ^ Kunkel RS (1 August 2010). "Headache". Disease Management Project: Publications. Cleveland Clinic. Archived from the original on 4 May 2013. Retrieved 6 August 2010.
  83. ^ Rothner AD (June 1995). "The evaluation of headaches in children and adolescents". Seminars in Pediatric Neurology. 2 (2): 109–118. doi:10.1016/s1071-9091(05)80021-x. PMID 9422238.
  84. ^ a b c d e Schultz BE, Macias CG (2011). "130: Headaches in Children". In Tintinalli JE, Stapczynski J, Ma O, Cline DM, Cydulka RK, Meckler GD (eds.). Tintinalli's Emergency Medicine: A Comprehensive Study Guide (7th ed.). New York, NY: McGraw-Hill. Archived from the original on 23 December 2016.
  85. ^ Scagni P, Pagliero R (April 2008). "Headache in an Italian pediatric emergency department". The Journal of Headache and Pain. 9 (2): 83–87. doi:10.1007/s10194-008-0014-1. PMC 3476181. PMID 18250964.
  86. ^ a b Kan L, Nagelberg J, Maytal J (January 2000). "Headaches in a pediatric emergency department: etiology, imaging, and treatment". Headache. 40 (1): 25–29. doi:10.1046/j.1526-4610.2000.00004.x. PMID 10759899. S2CID 39115552.
  87. ^ Burton LJ, Quinn B, Pratt-Cheney JL, Pourani M (February 1997). "Headache etiology in a pediatric emergency department". Pediatric Emergency Care. 13 (1): 1–4. doi:10.1097/00006565-199702000-00001. PMID 9061724. S2CID 33965477.
  88. ^ "What Causes Headaches in Children and Adolescents?". WebMD. Archived from the original on 7 May 2013. Retrieved 30 June 2010.
  89. ^ Medina LS, Kuntz KM, Pomeroy S (August 2001). "Children with headache suspected of having a brain tumor: a cost-effectiveness analysis of diagnostic strategies". Pediatrics. 108 (2): 255–263. doi:10.1542/peds.108.2.255. PMID 11483785.
  90. ^ American Headache Society Committee on Headache Education. "Headaches in Children". American Headache Society. Archived from the original on 16 May 2008. Retrieved 30 June 2010.
  91. ^ Guidetti V, Galli F, Fabrizi P, Giannantoni AS, Napoli L, Bruni O, et al. (September 1998). "Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study". Cephalalgia. 18 (7): 455–462. doi:10.1046/j.1468-2982.1998.1807455.x. PMID 9793697.
  92. ^ Wang SJ, Fuh JL, Lu SR (August 2009). "Chronic daily headache in adolescents: an 8-year follow-up study". Neurology. 73 (6): 416–422. doi:10.1212/WNL.0b013e3181ae2377. PMID 19605771. S2CID 32419124.
  93. ^ Torres-Yaghi Y, Salerian J, Dougherty C (April 2015). "Cardiac cephalgia". Current Pain and Headache Reports. 19 (4): 14. doi:10.1007/s11916-015-0481-4. ISSN 1534-3081. PMID 25819974.
  94. ^ Hashmi DH (21 Oct 2024). "Cardiac Cephalgia in Heart Attack". Health Learners.
[edit]